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The transformation of many small, abundant molecules is necessary both in a biological setting and in the 
chemical industry. In Nature, the activation of small molecules is promoted by metalloenzymes. However, 
many of these chemical transformations are thermodynamically demanding and consist of multi-electron 
redox processes. Understanding the secondary coordination sphere has played an integral role in 
determining the catalytic activity and selectivity of such transformations and has led to the development 
of bioinspired catalysts in order to mimic the native active site of the metalloenzyme. Due to its extensive 
modularity, the utilization of the pyridinediimine (PDI) metal complexes was targeted in this work to study 
the secondary coordination sphere and its relationship to the reactivity at the metal active site. The redox-
active PDI ligand scaffold containing a pendant base was used to synthesize a series of Fe(II) and Zn(II) 
complexes consisting of H-bond acceptors/donors in the secondary coordination sphere. The Zn(II) 
complexes are able to be protonated in the secondary coordination sphere, forming metal halogen 
hydrogen bonds (MHHBs). The use of these intramolecular H-bonds in the Zn complexes also serve to 
provide stabilization of the hydrosulfide (HS-) ligand, forming a six-coordinate Zn complex. The Fe(II) 
complexes were reduced under CO atmosphere, followed by protonation in the secondary coordination 
sphere. This resulted in stable, doubly reduced protonated species, capable of moving protons and 
electrons in and out of the system. The protonated Fe(II) complex was poised to deliver protons and 
electrons necessary to investigate nitrite (NO2-) reduction for the formation a dinitrosyl iron complex 
(DNIC). The reduction of nitrate (NO3-) for the synthesis of the DNIC was also explored and used to further 
investigate products of the reaction. Fe(II) PDI complexes with an incorporation of Lewis acids in the 
secondary coordination sphere were also synthesized and characterized in order to provide a better 
understanding of how redox inactive metals in the secondary coordination sphere of the PDI scaffold of 
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Chapter 1. Introduction 
1.1 Small Molecule Activation 
The transformation of small molecules into useful chemicals and fuels typically involves relatively 
unreactive abundant small molecules such as H2, CO2, CH4, NH3, O2, NO, N2O, etc. Several of these 
chemical transformations play an important role in both physiological and industrial applications.1-6 
Industrially, these molecules are transformed into more usable chemical feedstocks and energy 
resources, contributing to the renewable energy process.7-10 For example, the hydrocarbons used for 
fuels, as well as methanol used as a feedstock, can be catalytically produced from syngas (a mixture of 
H2 and CO) via the Fischer-Tropsch synthesis route.11  The production of syngas can be accomplished 
from many sources such as dry CO2 reforming of methane (DRM) (Eq. 1.1), consisting of two greenhouse 
gases, which makes this an attractive route for the formation of syngas.12, 13 
CO2 + CH4 → 2CO + 2H2  ∆H298 = +247 kJ/mol (1.1) 
Similarly, the Haber-Bosch process (Eq. 1. 2) makes use of N2 and H2 to produce NH3, used in fertilizers. 
This process is especially important due to the major role it plays in contributing to the nitrogen source 
available for global agriculture.14 
N2 + 3H2 → 2NH3  ∆H298 = +247 kJ/mol; ∆G= -33kJ/mol (1.2) 
Unlike the biological transformation of N2 to ammonia (nitrogen fixation) which occurs under ambient 
conditions, the Haber-Bosch process proceeds under high temperatures (500 ˚C) and pressures (~200 
atm).15 Among the many small molecule activation processes that are targeted, these two examples 
provide insight into the industrial aspect of small molecule activation. In both examples provided, a 
metal catalyst is needed to overcome the large kinetic barrier that these thermodynamically stable 
transformations have. In nature, metalloenzymes are used to overcome these barriers as they have the 




As described above, the catalytic transformations of these small, inert molecules into fuels such as CO, 
methanol, ammonia, or H2 are important in the chemical industry. In nature these conversions are 
facilitated by metalloenzymes containing inorganic active sites. The metal ion cofactors in 
metalloenzyme active sites play a role in catalytic biological reactions, such as electron transfer 
reactions.17 Examples of metal cofactors in the active sites (Figure 1.1) illustrate the fundamental need 
for use of transition metals such as zinc and iron. For example, the zinc dependent metalloenzyme, 
Carbonic Anhydrase II (CA) (Figure 1.2), is associated with catalyzing the rapid conversion of CO2 and 
water to carbonic acid (Eq. 1.3). The very high turnover numbers associated with the carbonic anhydrase 
catalyzed hydration of carbon dioxide make this one of the most rapid enzyme reactions known, with 
values up at 106 s−1.18,19   
Figure 1.1. Metal cofactors in proteins: iron in cytochrome c peroxidase20 (left), zinc in carbonic 
anhydrase18,19 (middle), and iron in CO dehydrogenase19 (right). (Figures made in PyMOL). 
Metalloenzyme active sites have two main components: the primary coordination sphere and the 
secondary coordination sphere. The ligands directly bound to the metal ion, such as the amino acid 
residues, make up the primary coordination sphere. The secondary coordination sphere is composed of 
groups not directly bound to the metal center, but still within a close proximity to the environment of 
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the metal cofactor (Figure 1.2). The active site of CA II also illustrates the presence of water molecules in 
the secondary coordination sphere, which are capable of forming hydrogen bonds that can play a role in 




Figure 1.2. Zinc coordination active site of Carbonic Anhydrase II illustrating the primary coordination 
sphere (black) and the secondary coordination sphere (blue).21 (Figure made in PyMOL). 
 Other secondary coordination sphere interactions include hydrogen bond acceptors, and amino acid 
residues which can participate in controlling the redox properties of the primary sphere as well as aid in 
the coordination of substrates.18b For example, the redox potential of iron-sulfur centers of 
metalloproteins, have been observed to be affected by hydrogen bonds. It has also been observed that 
the active site of hemoglobin I is selective for H2S (Figure 1.3) where the presence of a hydrogen bond 
donor in heme proteins helps to stabilize bound hydrosulfide (HS-) ligand.22 Comparatively, the presence 




Figure 1.3. Coordination of sulfide to a FeII heme complex (Figure made in PyMOL).23  
Other major enzymes participating in key small molecule activation include hydrogenase (H2 ↔ 2H+ + 
2e-), alcohol dehydrogenase, carbon monoxide dehydrogenase (CO2 + 2e- + 2H+ ↔CO + H2O), 
nitrogenase, nitrite reductase (NO2- + 2e- ↔ NO + H2O), and nitrate reductase (NO3- + 3e- ↔ NO + H2O), 
among many more. In order to study these significantly important biological systems at the molecular 
level, model complexes that share features parallel to that of the native enzymes are synthesized and 
characterized.  
1.3 Hydrogen Sulfide 
As discussed above, a sulfur-based ligand can be stabilized by the presence of hydrogen bonds in the 
secondary coordination sphere. For this reason, an area of research that has become of great interest is 
to explore H2S complexes. Similar to NO and CO, H2S has emerged as another gaseotransmitter in the 
regulatory system.22b,c, 24 However, H2S is also seen as an environmental pollutant found from the 
decomposition of bacterial and organic matters. Inorganic sources of H2S pollutant are also found in 
areas such as volcanic sediment, natural gas and sulfur deposits.25 
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Toxicity of H2S in the body comes from the fact that it can prevent cellular respiration by binding to iron 
from the mitochondrial cytochrome enzymes. Interaction with heme proteins such as cytochrome c 
oxidase, hemoglobin, and myoglobin is a common feature observed with H2S. The H2S level is balanced 
by reduction and oxidation of sulfur performed by two types of bacteria.25 In mammalian cells, H2S is 
generated by enzymatic and non-enzymatic pathways. Reverse transsulfuration involves the synthesis of 
cysteine from methionine using CBS as the catalyzing enzyme. Cystathionine β-synthase (CBS) is the 
enzyme responsible for catalyzing the condensation of cysteine with homocysteine to form 
cystathionine and H2S (Figure 1.4). The second step of reverse transsulfuration is catalyzed by 
Cystahionine γ-lyase (CSE) (Figure 1.4). CSE is the main H2S forming enzyme in the kidney, liver and the 
uterus.  
Figure 1.4. Cystathionine β-synthase and Cystahionine γ-lyase (CSE) (Figures made in PyMOL).25 
Despite its importance, efforts to synthesize metal-based H2S and HS- complexes in order to study the 
physiological reactivity remain sparse. Metal-sulfur interactions are significant in enzymes such as 
nitrogenases and hydrogenases. H2S exists in different protonation states at physiological pH. Reactivity 
with transition metal centers are complicated due to the variation of protonation state affecting the 
redox potential, nucleophilicity, and tendency to form insoluble metal salts.22c, 26 Ruthenium and iron 
based complexes have been reported, but stable Zn hydrosulfido complexes remain rare due to the lack 





sterics offered by the ligand platform.  An example of these zinc hydrosulfide complexes is that of the 
highly encapsulating pyrozolylborate ligand which allows for stabilization of the developed hydrosulfide 














Figure 1.5. Pyrozolylborate ligand illustrating the stability of Zn-OH. 
 
In some iron systems, it has been observed that the metal sulfide species is stabilized by secondary 
coordination sphere interactions.29 For example, the active site of hemoglobin (I) in Lucina pectinata 
binds H2S as seen above in Figure 1.3. In this case, the polarity plays a major role the stability of H2S 
bound to the iron center. High polar active sites can stabilize H2S, while non-polar sites cause a metal-
H2S dissociation. This means that the stereoelectronics of the heme site determine whether the H2S can 
stay bound or dissociate from the iron center, illustrating the importance of the secondary coordination 
sphere. 
 
1.4 Nitrate Reductase 
The chemical transformation of nitrate to nitrite is catalyzed biologically by an enzyme called nitrate 
reductase. This conversion of NO3- to NO2- plays a vital role in the nitrogen cycle as it is the first step in 
the denitrification process (Figure 1.6). The nitrogen cycle allows for interconversions of nitrogen 
compounds, with the help of various enzymes, to yield either ammonia or dinitrogen.  The nitrogen 
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cycle can be broken down into four main components: Nitrogen fixation, Nitrification, Nitrate 
Assimilation, and Denitrification.30 
Figure 1.6. The nitrogen cycle displaying the respective enzymes responsible catalyzing each step of the 
cycle.30    
 
Sources of nitrogen typically end up as water pollutants as nitrate and nitrite and must therefore be 
reduced to a more useful source. The research presented here will focus on the nitrate and nitrite 
reduction aspect of the nitrogen cycle. Nitrate reductases (NRs) catalyze the reduction of nitrate to 
nitrite (NO3- + 2H++ 2e-→ NO2- + H2O; E˚= 0.420 V).31 Nitrate reductases can be categorized as Eukaryotic 
Nitrate Reductases (Euk-NR), Assimilatory nitrate reductases (Nas), Respiratory Nitrate Reductase (Nar) 
and Periplasmic Nitrate Reductases (Nap).32 Each of these enzymes are fundamental nitrate reduction.  
The majority of nitrate reductases are mononuclear molybdenum enzymes where the molybdenum 
atom is coordinated by sulfur donors (Figure 1.7). 
8 
 
Figure 1.7. Active sites of Nitrate reductases (Euk-NR, periplasmic, and membrane bound)32b 
Reduction of nitrate to nitrite the first step of denitrification. Denitrification is an important process 
used by bacteria for energy generation and it plays central role in helping environmental problems such 
as nitrate accumulation and release of NO in the atmosphere.32b The biological process of denitrification 
consists of the reduction of nitrate (NO3-) to nitrogen gas.  Intermediate steps involved in denitrification 
include reduction of nitrate to nitrite followed by further reduction to nitric acid and then to nitrous 
oxide with a final reduction to dinitrogen. At this stage, N2 can be further reduced to ammonia (nitrogen 
fixation) by nitrogenase.  
Biologically, organisms use nitrate reductases for reducing nitrate to nitrite in order to generate energy 
for cellular function, to incorporate nitrogen into biomolecules, and to eliminate energy excess 
generated by cell metabolism.30 Nitrate reductases can also be subdivided as either assimilatory or 
dissimilatory. Direct conversion of nitrate to ammonia can occur via dissimilatory nitrate reduction. The 
initial reduction of NO3- to NO2- is achieved by the membrane-bound nitrate reductase.30 The catalytic 
nitrate reductase cycle (Figure 1.8) illustrates the five coordinate MoIV which can coordinate a nitrate 




Figure 1.8. Nitrate reductase catalytic mechanism.31 
The oxidation of MoIV to MoVI  was then followed with a further reduction by pentaheme cytochrome c 
nitrite reductase via a six electron/eight proton reduction of nitrite to ammonia (NO2-+ 8H++6e- →NH4++ 
2H2O; E˚= 0.34 V).32a, 33 
Assimilatory nitrate occurs in plants, algae, and bacteria.  This process takes place either via eukaryotic 
or prokaryotic pathways. The eukaryotic path consists of reduction of nitrate to nitrate via the 
eukaryotic nitrate reductase, and then reduction by the heme nitrite reductase to ammonia. In the 
prokaryotic system, the pathway involves reduction of nitrate via cytoplasmic nitrate reductase followed 
by heme nitrite reductase.30 Following the reduction of nitrate to nitrite is the reduction of nitrite to NO 
catalyzed by the cytochrome cd1 or the copper-containing nitrite reductase. 
1.5 Nitrite Reductase 
Nitric oxide (NO) plays a key role in biological systems as a messenger molecule for regulating immune 
function, serving as a neurotransmitter in the brain, and for activating iron regulatory factors in 
macrophages.24 Nitrite reductase (Figure 1.9) is the metalloenzyme responsible for efficiently reducing 
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NO2- to NO.  Nitrite reduction to NO (NO2- + e- + 2H+  NO + H2O E˚= 0.35 V) is a viable route for the 
investigation of complexes capable of mimicking the biological production of NO. NO targets metal 
containing proteins which can lead to the formation of dinitrosyl iron complexes (DNICs), as observed in 
iron sulfur proteins.3 Iron complexes capable of binding NO play an important role in many physiological 
and industrial applications.34 
Figure 1.9. Nitrite Reductase: Cytochrome-cd1.35, 36  
 1.5 The Oxygen Evolving Complex  
In many biological electron-transfer reactions, the use of redox inactive metals plays a key role in 
promoting the reactivity of the system. In nature, the four electron/four proton the photosplitting of 
water into O2 occurs during photosynthesis and is essential for human life. The water oxidation process 
is catalyzed within photosystem II (PSII) which contains a bridging oxo CaMn4 Cluster known as the 
oxygen evolving complex (OEC) (Figure 1.10).37  
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Figure 1.10. Overall structure of the Photosystem II dimer36b (left) and the structure of the oxygen 
evolving complex (OEC) (right).36e 
 
 The OEC undergoes four e- transfer events for the oxidation of H2O to O2 (2H2O  O2 + 4H+ + 4e-). The 
redox-inactive calcium ion is associated with three of the Manganese centers in a cubane motif (Figure 
1.11). The presence of calcium ion is vital for function since the OEC is known to be virtually inactive if 





Figure 1.11. ChemDraw representation found within Photosystem II, illustrating the use of the redox-
inactive Ca2+ (green).  
Each oxidation state of the OEC is known as an S-State as seen in the S-State cycle (Figure 1.12) where S0 
is the most reduced state and S4 is the most oxidized state.36 The OEC is repeatedly oxidized (one e- at a 
time) until it is oxidized four times leading to a high oxidation state of the manganese. The manganese  
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Figure 1.12. The simplified S-state cycle of the OEC in PSII.36  
 
Many manganese complexes have been synthesized as possible mimics of the OEC, some of which 
contain a Mn4Ca cluster resembling closely the cubane part of the native OEC. However, it is seen from 
the OEC that the redox inactive metal is a critical component in catalyzing the reaction. Agapie and 
coworkers have developed synthetic analogues that target the OEC structure in order to study and 
understand the role of the redox inactive metal (Figure 1.13).37 Replacement of the calcium various 
redox-inactive metals in these complexes have allowed for the systematic investigation of the effect 
each metal has on the system. The designs contain redox inactive metals such as Na+, Ca2+, Sr2+, Zn2+, and 
Y2+ ions which have that aid in the studying of the importance of these redox inactive metals. Figure 1.13 
illustrates two different complexes, a tri Mn oxo bridged cluster with a sodium metal rather than 










Figure 1.13. Synthetic models of the OEC featuring the cubane motif of the native OEC: Tri Iron Cluster 
(left)37a and Tri manganese cluster (right).37b  
 
The results of the study, illustrated by the cyclic voltammetry of these compounds, demonstrated a 
linear dependence between reduction potential and the pKa of the metal. The model of the Mn3 cluster 
with Y3+ resulted in a more positive potential than the Na+ which showed the least positive potential, 
suggesting that there is a correlation between reduction potentials and the charge of the redox inactive 
metals. This means that with the Y3+ ion, the Mn centers are easier to reduce due to the more highly 
charged Lewis acid metal ions withdrawing more e- density from the Mn centers. Another outcome of 
these experiments displayed of a linear correlation between the reduction potential of the Mn3 clusters 
and the pKa of the H2O molecule in the aqueous complex of the redox-inactive metal (Figure 1.14). 
Figure 1.14. The linear dependence shown by the graph of the E1/2 vs pKa of M(aqua)n+ ion.37b 
 
These results showed that having Sr2+ in the system has the same effect on the reduction potential of 
the manganese clusters as introduction of a calcium metal ion. This suggests that the OEC would still be 
active if Ca2+ were to be replaced with Sr2+. With this work, Agapie and coworkers have shown that 
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incorporation of a redox inactive metal affects the redox potential of the system. Similar to Agapie, we 
wanted to investigate the effect of the reduction potentials in our PDI ligand platform after 
encapsulation of redox inactive metals in the secondary coordination sphere.  
1.7 Ligand Design 
As described above, some transformations are quite complex and require multielectron redox processes 
which can be difficult to address when it comes to ligand design. For this reason, it is crucial to design a 
ligand in which both electrons and protons are able to flow in and out of the system. To address this 
need, the incorporation of redox activity into metal-ligand scaffolds that mimic relevant metalloenzymes 
have been utilized. This has further opened up new avenues to explore a variety of chemical 
transformations. Groups such as Borovik, Szymczak, and Fout have synthesized ligand platforms that can 
stabilize substrates through H-bond acceptors/donors (Figure 1.15).38  
 
 
Figure 1.15. MH3buea complex synthesized by Borovik and coworkers displaying H-bond donors in the 
secondary coordination sphere (left),38a tripodal system by Szymczak illustrating H-bond acceptors in the 
secondary coordination sphere (middle),38b and Fout’s ligand framework with H-bond acceptors in the 
secondary coordination sphere (right).38c 
 
The redox-active PDI ligand scaffold has the capability to be protonated while in a highly reduced state, 
allowing for the transfer of both protons and electrons to substrate.39,40 For this reason, the synthetically 
feasible PDI ligand makes the ideal candidate to use since they are redox-active, non -innocent ligands. 
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This means they are capable of both storing and releasing electrons, allowing access to redox states not 
typically available to the metal.39,40 This is particularly useful for facilitating multi-electron transfer 
reactions. The modular nature of the imine pendant arms also allows for potentially tuning chemical 
activity of the secondary coordination sphere.  These highly modular pendant groups can serve as H 
bond directors, proton shuttles, or nucleophiles. This allows for the study of two institutions merged 
into one: the secondary sphere (H-bonding interactions) and getting electrons in the system to carry out 
useful multi-electron transformations. The secondary sphere allows us to control the reactivity and 
behavior of the compounds. Given the modularity that the PDI scaffold provides, facile modifications in 
the secondary coordination sphere yields moieties containing H-bond acceptors/ donors, Lewis acids 










1.8 Research Objectives  
The research presented here targets the development of small inorganic complexes, consisting of a PDI 
ligand scaffold and studying the role of the secondary coordination sphere in these complexes.  The 
secondary coordination sphere plays a key role in how these bioinspired ligands tune their reactivities 
toward performing various chemical transformations.  The metal dihalide PDI complexes (ZnCl2, ZnBr2 
FeCl2 and FeBr2) were synthesized with varying pKa of the pendant bases in the secondary coordination 
sphere according to existing procedures and were characterized through infrared (IR) spectrometry, 
Mössbauer spectroscopy (if applicable), NMR spectroscopy, and X-ray crystallography. The 
diispropylamine PDI (didpa) complexes are able to form metal halogen hydrogen bonds (MHHBs) both in 
solid state and in solution. The protonation state of secondary coordination sphere was probed in order 
to determine the H-bond strength. DFT analysis was performed on the ZnCl2 and the ZnBr2 species for 
determination of the intramolecular H-bond. In solution, these complexes were introduced various H-
bond accepting solvents and analyzed through their 1H NMR spectra.  Additionally, the iron PDI 
complexes were reduced under CO atmosphere in order to study their reduction potentials and how 
altering the protonation state of the coordination sphere would affect the redox-active sites within the 
ligand scaffold. Furthermore, the reduced species were also used to measure how the pKa of the 
pendant amine is altered upon being incorporated into the PDI ligand. This complex can be used reduce 
nitrate and nitrite to nitric oxide.  
 In order to investigate the effect that introducing a redox inactive metal would have on the redox 
potential of the PDI complexes, a 15-crown-5 ether capable of chelating redox inactive metals was 
appended to our system. Incorporation of Na+ and Li+ allowed us to investigate the selectivity of the 
crown to the different alkali metals, as well as to explore the change incorporation of these metals 
would have on the redox potential of the PDI system.   
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Chapter 2. Synthesis of Metal Dihalide PDI Complexes: ZnII and FeII 
The microenvironment around the metal ion(s) of metalloprotein active site(s) is important in determining 
its structure, function, and reactivity.41 A key interaction in the primary and secondary coordination 
sphere of biological systems is hydrogen bonding.41-43 The non-covalent hydrogen bonding network(s) that 
form around the metal ion are capable of tuning the redox potentials, orienting substrate, and aiding in 
proton transfer reactions.41 Many of these chemical transformations in Nature consist of multi-electron 
processes. Therefore, model systems which incorporate redox-activity along with the ability to modify the 
secondary coordination sphere by providing H-bond donors/ acceptors is a feature that many aim for in 
developing ligand scaffolds.   
The importance of H-bonding in biological systems is observed in enzymes such as Myoglobin and 
Hemoglobin, both responsible for the reversible binding of dioxygen. The active site of myoglobin consists 
of a heme cofactor with a histidine residue coordinated to the iron center and a second histidine residue 
that sits in close proximity to the iron center. The framework of this enzyme provides an open 
coordination site to the iron center, allowing O2 to bind (Figure 2.1). Hydrogen bonds play a key role in O2 
binding and its stabilization, as observed with the H-bonding of bound O2 to the distal histidine in 
Myoglobin. It has been observed that altering the H-bonding networks significantly affects O2 binding 
affinity.42 
Figure 2.1. Structure of the active site of myoglobin illustrating the intramolecular H-bonding interaction 
to bound O2 (Figure made in PyMOL).43  
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In order to study the effects that H-bond interactions play in biological systems, synthetic models have 
been developed that portray features of the native active sites.  Synthetic systems such as those 
developed by Borovik and coworkers21,44 have focused on examining the H- bonding networks necessary 
for dioxygen binding and activation by metal complexes. The system contains three urea groups which 
can provide anionic donors and intramolecular hydrogen bonding. The secondary coordination sphere of 
their bioinspired design closely resembles that of the native active site in hemoglobin, making it an ideal 







Figure 2.2. The [Fe(IV)H3buea(O)]− complex illustrating intramolecular H-bonds formed with Fe-O.21,44 
 
In a similar study, H-bonding networks within the secondary coordination sphere are suggested to assist 
in the binding of O2, leading to activation of O2 and formation of the FeIII-OH and CoIII-OH complexes.45 
 Differences in the reactivity with dioxygen were observed throughout the series of these varied H-bond 
donor complexes (Figure 2.3).  
 
Figure 2.3. Urea-based tripodal complexes with varied intramolecular H-bond networks.45 
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The complex providing a higher number of intramolecular H-bonds showed reactivity with O2 whereas the 
one with no H-bonding network showed no reaction. These results further illustrate that altering the 
secondary coordination sphere can influence the reactivity of the primary sphere.  
Another example of the importance of hydrogen bonding comes from the production and oxidation of H2 
(Eq. 2.1). Hydrogenase enzymes used to catalyze the production and oxidation of H2 are Fe-Fe 
hydrogenase and NiFe Hydrogenase (Figure 2.4).  The amine in Fe-Fe hydrogenase facilitates the 
heterolytic cleavage of H2, yielding turnover frequencies of over 9000 s-1.46 Ni and Co functional models of 
these hydrogenase enzymes have been synthesized to catalyze the production and oxidation of H2. 
     
Figure 2.4. Structures of the [NiFe] hydrogenase (left) and [FeFe] hydrogenase (left) responsible for the 
production and oxidation of H2.47 
 
Dubois and coworkers have synthesized diphosphine ligand systems with the incorporation of pendant 
amines.48 These pendant amines can serve as proton relays that help accelerate intra and intermolecular 
proton mobility, overall facilitating the heterolytic cleavage of H2. The ability to promote fast proton 
transfer between mental and amine enables the proton relays to enhance the rates of catalytic reactions. 
Proton relays minimize the barriers for the movement of protons through use of pendant amines as 
illustrated in Figure 2.5.49 The stabilization of H2 binding is observed by the interaction between the two 
positioned pendant bases in the ligand platform. 
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Figure 2.5. [Ni(PCy2 NBz2)2]2+ synthetic model of Ni-Fe Hydrogenase for the oxidation of H2,  illustrating 
how pendant amines can serve as proton relays to stabilize the H2 intermediate.50 
 
Parson’s and coworkers have developed tripodal tetradentate tris(pyridyl-2-methyl)amine-based (TPA) 
ligands with hydrogen bond donors in the secondary coordination sphere (Figure 2.6). When providing 
hydrogen bond donors to the CuCl NHCOtBu pivaloylamido (LPiv-1,2,3) TPA complex, a change in redox 
behavior of the metal center is observed due to the metal halogen hydrogen bonds (MHHBs). In this 
system there is a change ranging from 0.025 - 0.500 V of the CuII/I couple.51,52  
Similarly, Mayer’s work demonstrates a change in the reduction potential of ~500 mV upon protonation 
of the iron complex of tetraphenylporphyrin (TPP) and the ruthenium complex of 4-methylimidazole (imH) 
(Figure 2.6).53 Likewise, a 350 mV shift is observed upon protonation of the pyridine−imidazole ligand in 
ruthenium bis(β-diketonato) complexes.49   
Figure 2.6. Left: [(LPiv-3)CuICl] complex illustrating the internal N–H · · · Cl–Cu (MHHB) hydrogen bonding- 
shifts in reduction potential range from ΔE1/2 ~0.025 - 0.500 V; middle: (acac)2RuII(py-imH) complex upon 
protonation with ΔE1/2 ~0.5 V; right: (TPP)FeII(MelmH)2 complex which exhibits a shift in reduction 
potential of ΔE1/2 ~ 0.350 V. 
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These complex models, however, rely on the metal center to perform redox chemistry.54,55 The work 
focused here utilizes the pyridinediimine (PDI) ligand scaffold which allows more than one coordination 
site to be accessible. The PDI system is highly modular and many functional groups can be appended which 
also allows for secondary coordination sphere tuning (Figure 2.7). 
Figure 2.7. Redox-active PDI ligand scaffold illustrating the modularity in the primary and secondary 
coordination sphere.  
The PDI ligand backbone has been shown to be redox active and can access four oxidation states, and can 
store up to three electrons.56-58 The storage of two electrons in the system can be observed in (Eq. 2.2). 
For this reason, multi-electron chemistry can be achieved, allowing electrons from the ligand to be stored, 
and flow in and out of the system. A redox active ligand, such as the PDI scaffold, allows for multi-electron 
redox process to be performed. Furthermore, we are able to use a redox active metal like zinc as the active 




In this study, we use the 2,6-diisopropylamine pendant group to synthesize zinc(II) and iron(II) PDI 
complexes in order to study the secondary coordination sphere and redox activity of these complexes. It 
has been previously observed that Fe(II) [(2,6-iPrC6H3)N=CMe)(N(iPr)2C2H4)N=CMe)C5H3N] (didpa) 
complexes are able to form H-bond interactions in the secondary coordination sphere. The protonated 
pendant amine of these didpa complexes provides intramolecular H-bonding to the Fe-X (X= Br- or OH-), 
allowing for the stabilization of complexes like the Fe(II) hydroxo ligand.39 A desire to further probe the 
secondary coordination sphere interactions and its potential to tune the redox activity of the primary 
coordination sphere came about from these results. 
2.1 Synthesis of the Didpa Ligand 
The ligand [(2,6-iPrC6H3)N=CMe)(N(iPr)2C2H4)N=CMe)C5H3N] (didpa, 2) was synthesized via a Schiff base 
condensation with starting materials [(2,6-iPrC6H3)N=CMe)(O=CMe)C5H3N] (1) and an excess of N,N-
diispropylethylenediamine in a 20 mL pressure vial. After 2 days at 90C, the solution changed from a pale 
yellow to a clear, dark yellow solution of 2 (Eq. 2.3).39 The solution was moved to the freezer after the 
addition of 10 mL of methanol. The solution remained in the freezer for 1 day to yield an off-white solid, 
which was filtered through a Buchner funnel to obtain a 90% yield. 
 
 
Fourier transform infrared (FTIR) and nuclear magnetic resonance (NMR) analysis confirm the identity of 





that no starting material is present (Figure 2.8).39 The FTIR also displays the imine (C=N) stretches at 1642 
cm-1 and 1581 cm-1, expected from the product. 
 
Figure 2.8. Solid-state FTIR spectrum of the didpa ligand. 
The 1H NMR spectrum of 2 reveals two septets at 3.79 ppm and 2.79 ppm, each integrating for two protons 
(Figure 2.9). The septet at 3.79 ppm is a result of the protons from the isopropyl group of the 2,6-
diisopropyl aryl group, while the one at 2.79 ppm is representative of the diisopropyl from the pendant 
amine. The ethylene bridge protons of the pendant arm can also be observed at 2.87 ppm and 3.60 ppm 
as two triplets. 




















Figure 2.9. 1H NMR spectrum of didpa (2) (500 MHz, CD2Cl2) (*represents solvent). 
2.2 Metallation with Zinc and Iron 
The zinc(II) complex was synthesized using [(2,6-iPrC6H3)N=CMe)(N(iPr)2C2H4)N=CMe)C5H3N] (didpa) in 
order to study the secondary coordination sphere interactions. The addition of ZnCl2 in THF to the 
methylene chloride solution of the free ligand, didpa, produced a color change from pale yellow to dark 
orange (Eq. 2.4). The solution stirred overnight, then filtered through a Celite plug. The filtered solution 




The solid-state IR spectrum of the zinc complex displays a stretch at 1639 cm-1 similar to that of the free 
ligand, from the C=N amine bond (Figure 2.10). The 1585 cm-1 is also observed, corresponding to the C=N 
bond from coordination of the diisopropyl pendant amine arm. 
 
Figure 2.10. Solid-state FTIR spectrum of Zn(didpa)Cl2 (3). 
Upon inspection of the 1H NMR spectrum, slight changes are observed from that of the free ligand (Figure 
2.11). The two septets are not fully visible as in the case of the free ligand.  Instead, there is one septet at 
2.97 ppm and one multiplet at 3.06 ppm. The septet represents the didpa diisopropyl protons and the 
multiplet is comprised of the protons from the diisopropyl group of the aryl ring, as well as two protons 
from the ethylene bridge.  The aromatic region has also changed. There are only three resonances 





well defined resonances present. The environment of the surrounding protons is now altered due to the 
introduction of the metal in the complex.  
 
Figure 2.11.  1H NMR spectrum of Zn(didpa)Cl2 (3) (500 MHz, CD2Cl2) (*represents solvent). 
The X-ray crystallographic analysis of the crystals formed from this product allowed us to observe the 
pincer ligand in which the zinc(II) sits in the N-N-N binding pocket of the complex. The geometry of a five-
coordinate zinc system can be determined by using a structural index parameter () defined by (β-α)/ 60, 
where β is the largest angle around the metal center and α is the second largest angle around the metal 
center.  A  value of zero represents a perfectly square pyramidal geometry, whereas a  value of 1 displays 
a trigonal bipyramidal geometry.59  The solid-state structure obtained of this five-coordinate complex 
(Figure 2.12) gives a  value of 0.34, suggesting it has distorted square pyramidal geometry. 
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Figure 2.12. Solid-state structure of Zn(didpa)Cl2 (3); Selected bond lengths (Å) and angles (deg): 
Zn(1)−Cl(1) 2.251(2), Zn(1)−Cl(2) 2.243(2), Zn(1)−N(1) 2.423(6), Zn(1)−N(2), 2.084(6), Zn(1)−N(3) 2.210(6), 
C(2)−N(1) 1.278(9), C(8)−N(3) 1.292(9), and Cl(1)Zn(1)Cl(2) 113.89(9), N(2)Zn(1)Cl(1) 127.74(18), and 
N(1)Zn(1)N(3) 147.9(2). 
The Zn(didpa)Br2 was synthesized in a similar manner as complex 3. A CH2Cl2 solution of the didpa ligand 
and a solution of ZnBr2 in THF were mixed together, resulting in an orange solution (Eq. 2.5). The solution 
stirred overnight before being filtered through a Celite plug and layered with Et2O. The resulting orange 
crystals were isolated and characterized to confirm the synthesis of Zn(didpa)Br2 (4). 
Similar to the Zn(didpa)Cl2 complex, the solid-state structure of 4 illustrates the five-coordinate complex 
(Figure 2.13). The solid-state FTIR spectrum of Zn(didpa)Br2 (4) exhibits stretches at 1635 cm-1 and 1584 
cm-1 due to the imine stretches of the complex (Figure 2.14). These stretches are similar to those of the IR 









Figure 2.13. Solid-state structure of Zn(didpa)Br2 (4). Selected bond lengths (Å) and angles (deg): Zn(1)-
N(2) 2.085(4), Zn(1)-N(3) 2.214(4), Zn(1)-Br(2) 2.3666(8), Zn(1)-Br(1) 3.3749(8), Zn(1)-N(1) 2.374(4), N(1)-
C(2) 1.274(6), N(2)-C(7) 1.340(6), N(3)-C(8) 1.261(7), C(2)-C(3) 1.496(7), C(7)-C(8) 1.499(7), N(2)-Zn(1)-
Br(2) 131.47(11), N(2)-Zn(1)-Br(1) 112.58(11), N(3)-Zn(1)-Br(1) 100.07(11), Br(2)-Zn(1)-Br(1) 115.95(3), 
N(3)-Zn(1)-N(1) 145.44(15).  
Figure 2.14.  Solid-state FTIR spectrum of Zn(didpa)Br2 (4). 
The NMR spectrum of Zn(didpa)Br2 further confirms the synthesis of the product (Figure 2.15). The 
aromatic region displays three peaks at 8.43 ppm, 8.21 ppm and 7.26 ppm which correspond to the 
protons of the aromatic rings of the complex. The appearance of a multiplet at 3.01 ppm integrates for 
six protons and is due to the protons from the isopropyl group of the diisopropyl aryl group and the 
diisopropyl group of the didpa ligand. Two of the protons from the ethylene bridge are also included into 




Figure 2.15. The 1H NMR spectrum of Zn(didpa)Br2 (4) (500 MHz, CD2Cl2) (*represents solvent). 
 
The Fe(II) analogue was also synthesized. In a nitrogen filled glovebox, the didpa ligand was dissolved in 
CH2Cl2 and carefully added to a solution of FeCl2 in THF to produce a dark blue solution (Eq. 2.6). The 
solution was stirred for one day and then filtered through celite to remove any impurities. 
 
The IR spectrum of 5 displays two stretches at 1619 cm-1 and 1581 cm-1, corresponding to the C=N amine 






Figure 2.16. Solid-state FTIR spectrum of Fe(didpa)Cl2 (5).  
 
However, the synthesis could not be confirmed by means of NMR due to the paramagnetic nature of the 
species (Figure S3). A solid-state structure (Figure 2.17) was obtained to confirm the synthesis. The solid-
state structure reveals a five-coordinate distorted square pyramidal geometry ( =0.34). The measured 
effective magnetic moment (µeff) for this complex can be measured in solid-state via a magnetic 
susceptibility balance, or in solution by Evan’s NMR method measurements.60 The solid-state also allows 
a measured µeff value of 5.8 µB and 5.7 µB in solution, suggesting a high spin (S=2) Fe(II) center. 
Figure 2.17. Solid-state structure of Fe(didpa)Cl2 (5) (left) and Room-temperature zero-field 57Fe 
Mössbauer spectrum of Fe(didpa)Cl2 (5) (right) [δ = 0.882(3) mm/s, ΔEQ = 1.841(7) mm/s]. Selected bond 
lengths and angles: Fe(1)−Cl(1) 2.2959(12), Fe(1)−Cl(2) 2.2790(14), Fe(1)−N(1), 2.285(3), Fe(1)−N(2) 
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2.117(3), Fe(1)−N(3) 2.192(3), C(2)−N(1) 1.283(5), C(8)−N(3) 1.280(6), and Cl(1)Fe(1)Cl(2) 109.52(6), 
N(2)Fe(1)Cl(1) 124.58(9), and N(1)Fe(1)N(3) 146.39(13). 
 
In order to confirm the oxidation state of the iron center, the room-temperature Mössbauer spectrum of 
the complex was analyzed. The results yielded an isomer shift (δ) of 0.882(3) mm/s and a quadrupole 
splitting (EQ) value of 1.841(7) mm/s, consistent with the parameters of other previously synthesized high-
spin iron center complexes.61-64 Relevant Mössbauer parameters of Fe(II) PDI complexes are summarized 
in Table 2.1.  









2.3. Protonation of the Zn(II) and Fe(II) Species 
The pendant base of the zinc(II) complex was protonated with a weak acid, ammonium 
hexafluorophosphate (NH4PF6). A yellow solution of Zn(didpa)Cl2 in THF was reacted with NH4PF6 in MeOH, 
and allowed to stir overnight (Eq. 2.7). The solution was filtered through a celite plug and layered with 
diethyl ether. The solid-state structure revealed the formation of the protonated complex, 
[Zn(Hdidpa)Cl2][PF6] (6). 
PDI complex Isomer shift (δ) 
[mm/s] 
Quadropole splitting (ΔEQ) 
[mm/s] 
Ref 
Fe(didpa)Cl2 0.882(3) 1.841(7) 65 
[Fe(Hdidpa)Cl2][PF6] 0.863(45) 1.933(8) 65 
Fe(didpa)(CO)2 −0.061 1.43 65 
[Fe(Hdidpa)(CO2][PF6] -0.075(5) 1.435(8) 65 
Fe(MeOPDI)Br2 0.644 (9) 1.13 (2) 57 
Fe(MeNHPDI)Cl2 0.835 (7) 1.06 (1) 58 
Fe((Me)2NPDI)Cl2 0.840 (2) 1.215 (4) 58 
Fe(BpinPDI)Cl2 0.868 (5) 1.23 (1) 58 
Fe(MeNHPDI)(CO)2 -0.076 (9) 1.25 (2) 58 
Fe((Me)2NPDI)(CO)2 -0.061 (1) 1.07 (2) 58 
Fe(BpinPDI)(CO)2 -0.061 (4) 1.510 (8) 58 
(iPrEtPDI)FeN2 0.37 1.75 66 




The IR spectrum contains an amine stretch (C=N) at 1642 cm-1 (Figure 2.18).  However, the NH stretch 
expected to be observed from this product is not present. This absence could be a cause of the 
intramolecular hydrogen bonding of this complex. This lack of a resolved NH stretch is common in other 
complexes that are involved in intramolecular hydrogen bonds.67 Also observed is the PF6- counterion at 
832 cm-1. 
 
Figure 2.18. Solid-state FTIR spectrum of [Zn(Hdidpa)Cl2][PF6] (6). 
Upon inspection of the 1H NMR spectrum (Figure 2.19), a new resonance is observed at 8.50 ppm as a 
result of the protonated diisopropylamine pendant arm of the complex. There is a clear downfield shift of 
this N-H resonance to the aromatic region due to intramolecular hydrogen bonding. Similar to the 1H NMR 
of the free ligand, the aromatic region of the spectrum contains five distinct resonances, corresponding 





two triplets. At 3.86 ppm we observe a septet corresponding to the diisopropyl protons of the pendant 
amine. 
 
Figure 2.19. 1H NMR of [Zn(Hdidpa)Cl2][PF6] (6) (500 MHz, CD2Cl2) (*represents solvent). 
The solid-state structure (Figure 2.20) indicates square pyramidal geometry of 6 ( = 0.00). The solid-state 
structure also exhibits the intramolecular hydrogen bonding, previously determined from the proton 
NMR. Hydrogen bonding occurs between the zinc, one of the chlorine atoms, and the protonated pendant 
diisopropyl (Zn-Cl···H-N), making a metal halogen hydrogen bond (MHHB). A further indication of 
intramolecular H-bonding can be seen in the solid-state structure by the fact that the N-H group is directed 
toward the Cl atom that it is H-bonding with. The bonds lengths yielded 2.17(6) Å for the N-H···Cl distance 
and 3.152 (6) Å for the N···Cl distance. Steiner describes a strong hydrogen bond of a Cl···H to be 1.2-1.5 
Å, the N-H···Cl angle of 170-180, and the N···Cl distance of 2.5-3.2 Å.52 The parameters of what constitutes 
medium and weak hydrogen bonds are summarized in Table 2.2.  The presence of MHHBs in other systems 
result in similar spectroscopic data that we observe in [Zn(Hdidpa)Cl2][PF6] (6).68 The Zn-Cl bond distance 
afforded a value of 2.2696 (18) Å. The N-H···Cl angle of this complex is 172 (5). 
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Figure 2.20. Solid-state structure of [Zn(Hdidpa)Cl2][PF6] (6) (30% probability) displaying the capability of 
the protonated pendant base to form intramolecular hydrogen bonds. Selected bond lengths (Å) and 
angles (deg): Zn(1)−Cl(1) 2.2696(18), Zn(1)−Cl(2) 2.2346(19), Zn(1)−N(1) 2.240(5), Zn(1)−N(2) 2.079(5), 
Zn(1)−N(3) 2.251(5), N4-(H1N) 0.99(6), Cl(1)···H(4N) 2.17(6), N(4)···Cl(1), 3.152(6), C(2)−N(1) 1.252(8), 
C(8)−N(3) 1.277(8), and Cl(1), Zn(1)Cl(2) 113.45(7), N(2) Zn(1)Cl(1) 143.89(15), N(1) Zn(1)N(3) 143.1(2), 
and N(4)-H(1N)···Cl(1) 172(5). 
 
Table 2.2. Parameters for weak, medium, and strong H-bonds.48 
 Strong Medium Weak 
H···X bond length (Å) 1.2- 1.5 1.5-2.22 >2.2 
N···X bond distance (Å) 2.2- 2.5 2.5-3.2 >3.2 
N-H···X bond angle (˚) 170-180 >130 >90 
 *X= Halide (Cl, Br, I, etc.) 
 
To compare the intramolecular H-bonding strength, [Zn(Hdidpa)Br2][PF6] (7) was also synthesized in the 
same manner as 3. Similar to [Zn(Hdidpa)Cl2][PF6], an NH stretch is not observed in the solid-state FTIR 
spectrum (Figure 2.21). The PF6- counterion from the synthesis is observed at 835 cm-1. 
 
Figure 2.21. Solid-state FTIR spectrum of [Zn(Hdidpa)Br2][PF6] (7). 
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The complex, [Zn(Hdidpa)Br2][PF6], was characterized by  1H NMR and the solid-state structure. The 1H 
NMR spectrum (Figure 2.22), analogous to 6, [Zn(Hdidpa)Br2][PF6] (7) illustrates an N-H bond resonance 
shifted downfield. The resonance is found to be at 7.78 ppm as opposed to 8.50 ppm 
in[Zn(Hdidpa)Cl2][PF6]. This difference suggests a weaker intramolecular H-bond interaction in 
[Zn(Hdidpa)Br2][PF6] (7). 
 
Figure 2.22. 1H NMR of [Zn(Hdidpa)Br2][PF6] (7) (500 MHz, CD2Cl2) (*represents solvent). 
In comparison to [Zn(Hdidpa)Cl2][PF6], the solid-state structure of the [Zn(Hdidpa)Br2][PF6] shows an N-
H···Br distance of 2.45(4) Å and the N···Br distance of 3.309 (3) Å (Figure 2.23). These bond distances are 
slightly longer than those seen in the [Zn(Hdidpa)Cl2][PF6] species, as expected due to a weaker H-bond 
interaction. The N-H···Br angle is 174 (3). This follows the trend of MHHB strength described by Sherwood 
who describes trend to be H-F<<H···Cl≤ H···Br< H···I, with H-F being the shortest bond length.52 Again, it is 





Figure 2.23. Solid-state structure of [Zn(Hdidpa)Br2][PF6] (7) (30% probability). Selected bond lengths (Å) 
and angles (deg): Zn(1)-N(2) 2.081(3), Zn(1)-N(3) 2.270(3), Zn(1)-Br(2) 2.3746(7), Zn(1)-Br(1) 2.3992(6), 
Zn(1)-N(1) 2.233(3), N(1)-C(2) 1.283(5), N(2)-C(7) 1.332(5), N(3)-C(8) 1.277(5), C(2)-C(3) 1.495(5), C(7)-C(8) 
1.499(6), N(4)-H(1N) 0.86(4), N(4)-H(1N)…Br(1) 2.45(4), N(4)...Br(1) 3.309(3), N(2)-Zn(1)-Br(2) 145.94(9), 
N(2)-Zn(1)-Br(1) 100.81(9), N(3)-Zn(1)-Br(1) 98.02(8), Br(2)-Zn(1)-Br(1) 113.17(3), N(3)-Zn(1)-N(1) 
143.06(12), N(4)-H(1N)-Br(1) 174(3). 
 
The protonated Fe(II) analogue was synthesized similarly to the protonated Zn(II) complexes. Complex 5 
was dissolved in methylene chloride and added to a MeOH solution of NH4PF6 (Eq. 2.8). The solution stirred 
for one day and was filtered through a celite plug. Purple crystals identified as [Fe(Hdidpa)Cl2][PF6] (8) 
were obtained upon layering the DCM solution with diethyl ether and leaving for one week in the freezer 
at -10 C. 
 
The solid-state FTIR spectrum of 8 illustrates a stretch at 1622 cm-1 and 1582 cm-1 from the imine bonds 




intramolecular H-bonding interactions. The lack of an NH stretch in the FTIR spectrum has also been 
observed in other Fe(II) didpa complexes.39 
 
Figure 2.24.  Solid-state FTIR spectrum of [Fe(Hdidpa)Cl2][PF6] (8). 
The paramagnetic nature of complex 8 resulted in a 1H NMR spanning a much larger window in 
comparison to diamagnetic species (Figure S6). In order to confirm the synthesis of [Fe(Hdidpa)Cl2][PF6] 
(8), the solid-state structure was obtained (Figure 2.25). The solid-state structure reveals a five-coordinate 
iron center with a distorted square pyramidal geometry ( = 0.06). The measured value of the µeff is 4.8 µB 
in the solid state and 4.7 µB in solution. Again, we observe the NH group facing the Cl- group as was 
observed in both the [Zn(Hdidpa)Cl2][PF6] (6) and [Zn(Hdidpa)Br2][PF6] (7). The Mössbauer spectrum of 8 
further confirms an iron(II) metal center (Figure 2.25). The Mössbauer room-temperature parameters 




Figure 2.25. Solid-state structure of [Fe(Hdidpa)Cl2][PF6] (8) with PF6- omitted for clarity, displaying a 
MHHB (left) and room-temperature zero-field 57Fe Mössbauer spectrum of [Fe(Hdidpa)Cl2][PF6] (8)  (right); 
[δ = 0.863(4) mm/s and a ΔEQ of 1.933(8)]. Selected bond lengths (Å)  and angles (deg): Fe(1)−Cl(1) 
2.327(2), Fe(1)−Cl(2) 2.263(2), Fe(1)−N(1) 2.225(6), Fe(1)−N(2) 2.102(5), Fe(1)−N(3) 2.215(7), N4- (H4N) 
1.00(2), Cl(1)···H(4N) 2.18(3), N(4)···Cl(1) 3.157(8), C(2)−N(1) 1.282(8), C(8)−N(3) 1.283(9), and 
Cl(1)Fe(1)Cl(2) 111.94(9), N(2)Fe(1)Cl(2) 142.54(17), N(1)Fe(1)N(3) 146.1(2), and N(4)-H(4N)···Cl(1) 
166(10).  
 
2.4 Reduction of Fe(didpa)Cl2 
In order to study the relationship between the ligand-based redox activity of the primary sphere and the 
protonation state of the secondary coordination sphere, the Fe(II) analogue was synthesized. Due to the 
redox inactivity of the Zn(II) metal center, the redox active Fe(II) center is needed to study this 
relationship.  The dichloride compound, 5, can be reduced with NaHg amalgam under CO to make the 
carbonyl compound, Fe(didpa)(CO)2 (9). A Fischer-Porter tube was pressurized with 20 psi of CO and left 
to stir vigorously overnight (Eq. 2.9). Dark green crystals of Fe(didpa)(CO)2 (9) were obtained by slow ether 
evaporation of a filtered ether solution.  
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The dashed line in the ChemDraw representation of Fe(didpa)(CO)2 represents reduction of the PDI ligand 
is reduced by two electrons which are delocalized throughout the backbone ligand.  
The FTIR spectrum (Figure 2.26) of this complex shows two stretching frequencies at 1940 cm-1 and 1871 
cm-1, corresponding to the carbonyl ligands present in the synthesized complex. 
 
Figure 2.26. Solid-state FTIR spectrum of Fe(didpa)(CO)2 (9) displaying the CO stretches. 
The 1H NMR spectrum of the diamagnetic complex, Fe(didpa)(CO)2, confirms the synthesis of this complex 
(Figure 2.27). The two triplets found at 4.25 ppm and 2.88 ppm integrate for the four protons of the 
ethylene bridge. There is a septet at 3.10 ppm integrating for the two protons of the diisopropylamine 
didpa arm. Another septet is also observed at 2.51 corresponding to the two protons of the diisopropyl of 
the aryl group. The 13C NMR of Fe(didpa)(CO)2 (9) was also obtained to further confirm the presence of 




the CO ligands (Figure S7) displayed at 214 ppm, consistent with the resonances observed in other Fe(CO)2 
PDI complexes.57,58  
 
Figure 2.27. 1H NMR spectrum of Fe(didpa)(CO)2 (9). 
The solid-state structure of Fe(didpa)(CO)2 (9) (Figure 2.28) shows the C=N imine double bonds are 
elongated from 1.283(5) and 1.280(6) Å in the dichloride species to 1.3330(7) and 1.329(7) Å in the 
Fe(didpa)(CO)2 (9). To confirm the oxidation state of the iron center, the room temperature Mössbauer 
spectrum was analyzed (Figure 2.28). Based on the Mössbauer parameters of 9 (∆EQ= 1.43, δ= -0.06 mm/s) 
along with the Cimine-Nimine bond lengths, it was determined that the metal center is Fe(II) with a doubly 
reduced PDI ligand.   
41 
 
Figure 2.28. Solid-state structure of Fe(didpa)(CO)2 (9) (30% probability) (left) and room-temperature 
zero-field 57Fe Mössbauer spectrum (right) of Fe(didpa)(CO)2 (9) [∆EQ= 1.43, δ= -0.06 mm/s]. Selected 
bond lengths (Å) and angles (deg): Fe(1)−C(31) 1.774(6), Fe(1)−C(30) 1.788(7), Fe(1)−N(1) 1.961(5), 
Fe(1)−N(2) 1.846(4), Fe(1)−N(3) 1.960(5), C(2)−N(1) 1.330(7), C(8)−N(3) 1.329(7), and C(31)Fe(1)C(30) 
98.9(3), N(2)Fe(1)C(31) 149.2(3), and N(1)Fe(1)N(3) 156.99(19). 
 
2.5 Protonation of the Reduced Fe(II) PDI Complex 
The Fe(didpa)(CO)2 complex can be protonated similarly to Fe(didpa)Cl2 (5) in order to study the 
relationship between the protonation state of the base and the redox activity of the iron center. A solution 
of ammonium hexafluorophosphate in CH3OH was introduced to a solution of [Fe(didpa)(CO)2] in DCM 
and left to stir for one day (Eq. 2.10). Careful layering of the filtered DCM solution with diethyl ether 
yielded dark purple crystals identified as [Fe(Hdidpa)(CO)2][PF6] (10).  
 
The solid-state FTIR spectrum illustrates the CO stretches at 1945 cm-1 and 1879 cm-1 (Figure 2.29). The 







Figure 2.29. Solid-state FTIR spectrum of [Fe(Hdidpa)(CO)2][PF6] (10). 
Although the FTIR spectrum lacks the N-H stretch, the 1H NMR spectrum (Figure 2.30) shows the N-H 
resonance at 7.60 ppm. Upon protonation of the reduced species, we observe a few other changes in the 
NMR spectrum. A singlet is observed at 8.18ppm responsible for three protons of the aryl group. The 
ethylene bridge proton resonances are found at 4.65 ppm and 3.82 ppm. The septet from the two protons 
of the diisopropylamine pendant base are found within the multiplet at 2.51 ppm. 
 
Figure 2.30. 1H NMR spectrum of [Fe(Hdidpa)(CO)2][PF6] (10). 
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The zero-field Mössbauer parameters of 10 (ΔEQ= 1.435(8), δ= -0.075(5) mm/s) suggest the oxidation state 
remains Fe(II) as was observed in the unprotonated species. The solid-state structure (Figure 2.31) 
illustrates the protonated amine in the secondary coordination sphere. The solid–state structure reveals 
a five-coordinate Fe center with a square pyramidal geometry ( = 0.12). The Cimine-Nimine bond lengths 
calculated suggest no change in oxidation state of the ligand upon protonation of the pendant amine.  
Figure 2.31. Solid-state structure (30% probability) (left) and the Mössbauer spectrum (right) of 
[Fe(Hdidpa)(CO)2][PF6] (10). Only the H atom of the protonated diisopropylamine is shown, and the PF6- 
counterion is omitted for clarity. Selected bond lengths (Å) and angles (deg): Fe(1)−C(1) 1.779(2), 
Fe(1)−C(2) 1.7821(18), Fe(1)−N(1) 1.9617(15), Fe(1)−N(2) 1.8452(15), Fe(1)−N(3) 1.9461(16), N4-(H4N) 
0.74(3), C(4)−N(1) 1.317(2), C(10)−N(3) 1.329(3), and C(1)Fe(1)C(2) 94.29(9), N(2)Fe(1)C(1) 151.19(8), and 
N(1)Fe(1)N(3) 154.70(6). 
 
2.6. Electrochemistry of Fe(II) PDI Complexes 
As previously discussed, the redox activity of iron complexes can be influenced by the secondary 
coordination sphere. In order to investigate the relationship between the redox activity and alterations 
made in the secondary coordination sphere, the cyclic voltammograms of complex 9 and 10 were analyzed 







Figure 2.32. Left: Cyclic voltammogram of 0.005 M Fe(didpa)(CO)2 (9) (black line) and 0.010 M 
[Fe(Hdidpa)(CO)2][PF6] (10) (blue line); 0.1 M [(nBu)4N][PF6] in DCM, 200 mV/s scan rate. Right: Plot of 
Ecathodic peak current versus square root of the scan rate for Fe(didpa)(CO)2 (9) (black) and 
[Fe(Hdidpa)(CO)2][PF6] (10) (red) shows a linear correlation, to confirm the quasi-reversible process in 
CH2Cl2. 
Previous studies have shown that the one electron oxidation involves the redox-active PDI ligand as 
opposed to the metal center.56-58 The PDI ligand scaffold forms [FePDI(CO)2]+ via the quasi-reversible one 
electron oxidation. The cyclic voltammograms of 9 and 10 display the quasi-reversible one electron 
oxidation of the PDI ligand platform expected (Figure 2.32, above). The neutral form, complex 9, showed 
the oxidation event at E1/2= -0.590 V vs. ferrocene. Protonation of the pendant amine in the secondary 
coordination sphere shifts the event to E1/2= -0.485 V vs. ferrocene, a difference of 105 mV.  This suggests 
that the ligand is more difficult to oxidize once the pendant arm is protonated. However, typical shifts 
upon protonation of different metal complexes where the ligand is directly bound to the metal center 
tends to be around a 500 mV shift.68,69 Overall, the electrochemical data indicates very little change in the 
reduction potential upon protonation of the PDI ligand scaffold, making this system a suitable system for 
chemical transformations requiring the use of both protons and electrons.  
In addition to exploring the relationship between the protonation state and redox activity, it was also 
necessary to determine how protonation of the secondary coordination sphere affected the basicity of 











































is relatively close to that of Hünig’s base (pKa= 18.8) which suggests that the presence of the ethylene 
bridge prevents a wild deviation in the basicity of the pendant amine. The results of both the 
electrochemistry as well as the pKa determination indicated no change in the oxidation state upon 
protonation in the secondary coordination sphere. This was further confirmed by the Cimine-Nimine bond 
lengths, Mössbauer parameters, and CO stretches (Table 2.3). This means that adding a proton to a highly 
reduced species has left it essentially unchanged, inconsistent with the redox behavior observed in other 
systems, such as Mayer’s, which experience ~500 mV shift upon protonation.53 
Table 2.3. Spectroscopic and electrochemical data of 5 and 7.  









Fe(didpa)(CO)2 −0.061 1.43 1.329 (3), 1.330 (7) 1940, 1871 
[Fe(Hdidpa)(CO2][PF6] -0.075(5) 1.435(8) 1.329 (3), 1.317 (2) 1945, 1879 
 
2.7. Hydrogen Bonding in Solution 
Intramolecular hydrogen bonding in [Zn(Hdidpa)Cl2][PF6] (6), [Zn(Hdidpa)Br2][PF6] (7) and 
[Fe(Hdidpa)Cl2][PF6] (8), and [Fe(Hdidpa)(CO)2][PF6] (10) were observed through the solid-state structures. 
However, it was necessary to investigate the intramolecular H-bonding in solution. It was also important 
to study how the environment around the metal center was altered upon binding and protonation of the 
pendant amine.  In order to establish an understanding of how the basicity changes upon binding to the 
complex, the pKa of the pendant diisopropylamine in the didpa ligand was determined. The pKa values of 
Zn(didpa)Cl2 were determined by establishing equilibria with a base of a known pKa, triethylamine. These 
experiments were performed in acetonitrile solutions and monitored by NMR spectroscopy. The pendant 
amine of the unprotonated species was measured to be 18.4, while the pKa of Hünigs base is 18.8. This 
means that the basicity of the diisopropylamine is not altered upon binding. The pKa did not change in the 
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didpa complex perhaps due to the ethylene bridge serving as an insulator from the metal. The PDI ligand 
does not affect the pKa of the pendant amine which differentiates the PDI from other systems.70 
In the solid state, we observed a metal halogen hydrogen bond (MHHB) in [Zn(Hdidpa)Cl2][PF6] (6) and 
[Zn(Hdidpa)Br2][PF6] (7).  In order to show the hydrogen bonding interaction of [Zn(Hdidpa)X2]+ (where X= 
Cl- or Br-) species in solution, analysis by NMR spectroscopy was performed.  The N-H resonances of both 
6 and 7 are shifted downfield to the aromatic region. The downfield shift is representative of the presence 
of an intramolecular hydrogen bond in the system.44a,71-73  Since Cl is more electronegative than Br, the 
proton resonances in 6 are more deshielded than those in 7. Therefore the N-H resonance for 
[Zn(Hdidpa)Cl2][PF6] (6) is further downfield than that of [Zn(Hdidpa)Br2][PF6] (7) which is expected due to 
the weaker MHHB interaction from the bromide. The results from the NMR experiment confirm that in 
solution, the H-bonds are intact. In order to investigate the strength of the H-bond in each of the 
[Zn(Hdidpa)Cl2][PF6] (6) and [Zn(Hdidpa)Br2][PF6] (7), it was necessary to try and break that H-bond. One 
way to accomplish this is to titrate in a better H-bond acceptor that will interact with that H-bond more 
favorably the MHHB. The three solvents used to probe the H-bond of these complexes included acetone, 
DMF, and DMSO. Using the Beta scale of hydrogen bonding ability (HBA), basicities determined by 
solvatochromatic comparison method, DMSO exhibited the most H-bonding ability (Table 2.4).74 Upon 
titration of each solvent, the N-H resonance was monitored. Acetone had the smallest chemical shift in 
the 1H NMR, correlating well with its H-bond accepting ability.  As expected, there is a clear shift observed 
when the complexes are titrated with DMF and DMSO. The binding isotherms for all three solvents 




Table 2.4. Solvents with their H-bond accepting abilities. 
 
Figure 2.33. Left: Binding isotherms of the 1H NMR titrations of 6 with deuterated solvents of different H-
bond accepting strength. 
As seen from the binding isotherms, there is a large downfield shift of the N-H resonance in DMF and 
DMSO, but no shift when there is an addition of acetone. The large chemical shift of the N-H resonance 




Figure 2.34. 1H NMR chemical shift of Zn(didpa)Cl2 (6) in CD2Cl2 (top) and upon addition of DMF-d7 
(bottom), illustrating the shift in the N-H resonance. 
 
Since the Zn(didpa)Br2 is expected to have a weaker intramolecular H-bond, the strength of the H-bond in 
solution was also analyzed through a series of titrations. Similar to [Zn(Hdidpa)Cl2][PF6] (6), a large shift 
was noted for the N-H resonance upon addition of DMF and DMSO (Figure 2.35). However, unlike 
[Zn(Hdidpa)Cl2][PF6], a small shift of the N-H resonance was also observed with the introduction of 
acetone likely as a result of a weaker MHHB in [Zn(Hdidpa)Br2][PF6] (7). The weaker MHHB therefore 
allows interaction with poorer H-bond acceptors like acetone.  Another feature to notice is that the shifts 
in the N-H resonance for DMF and DMSO are much larger than that of the [Zn(Hdidpa)Cl2][PF6] (6). This 
larger shift highlights a larger hydrogen bond interaction because there is a weaker intramolecular 
interaction. From the titration experiments performed, the conclusion is that the bromide forms a weaker 
MHHB bond than chloride. The weak H-bond acceptor, acetone, showed a slight interaction in the 
bromide analogue due to a weaker intermolecular H-bond interaction. There is also a much larger 
interaction observed with the two other solutions for the same reason. These NMR titrations give us an 
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idea of how these intermolecular H-bonds behave in solution. However, in order to measure the 
interactions in solid state, the strength of the H-bond was determined by computational analysis. 
Figure 2.35. Binding isotherms of the titration of [Zn(Hdidpa)Br2][PF6] (7) with hydrogen bond acceptors 
acetone (black squares), DMSO (blue circles), and DMF (red triangles).  
It is proposed that these MHHB get weaker going down the periodic table, and this trend was observed in 
[Zn(Hdidpa)Cl2][PF6] (6)and [Zn(Hdidpa)Br2][PF6] (7). To verify this, gas phase computational density 
functional theory (DFT) calculations were performed on both the [Zn(Hdidpa)Cl2][PF6] (6) and 
[Zn(Hdidpa)Br2][PF6] (7) complexes. Using the solid-state structure of [Zn(Hdidpa)Cl2][PF6] (6) as a starting 
basis, the energy of the H-bond in [Zn(Hdidpa)Cl2][PF6] (6) was calculated. The energy is calculated once 
again when the diisopropylamine group is rotated away, yielding a difference of 6 kcal/mol (Figure 2.36). 
In order to measure the H-bond strength in [Zn(Hdidpa)Br2][PF6] (7), this similar process was performed 
using DFT calculations and a smaller value is obtained (5 kcal/mol). These results further support the 


































Figure 2.36. Computational DFT studies of [Zn(Hdidpa)Cl2][PF6] (6) showing MHHB (left) and with the 
diisopropylamine group rotated (right). 
 
2.8. Reactivity of Didpa with Hydrogen Sulfide 
The didpa ligand was revealed to form intramolecular H-bonding within the secondary coordination in 
both solid state and in solution, providing stabilization of metal halogen hydrogen bonds (MMHBs) and 
other substrates. It was previously observed that the didpa scaffold allowed for the stabilization of an Fe-
OH species through intramolecular hydrogen bonding.39 In the neutral form, the didpa ligand can serve as 
an H-bond acceptor while the protonated form of the ligand can function as an H-bond donor (Figure 
2.37).  
Figure 2.37. The didpa ligand scaffold acting as an H-bond acceptor (left) and an H-bond donor (right) 
which can use intramolecular H-bonding to stabilize substrates. 
Systems containing hydrogen bond acceptors have been shown to aid in the stabilization of various 
substrates, such as hydrosulfide.71-73 However, the synthesis of ligand systems containing H-bond 
acceptors remain rare and there is only a handful of stable hydrosulfide complexes that illustrate 
stabilization via secondary coordination sphere interactions. Some groups who have incorporated H-bond 
acceptors in their ligand design includes Borovik, Szymczak, and Fout.38 Given that the neutral form of the 
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didpa ligand can serve as a hydrogen bond acceptor, didpa was an ideal candidate for stabilization of the 
SH bond.  
The [Zn(didpa)Cl2SH]- complex was synthesized upon addition of NBu4SH in DCM or MeCN to a solution of 
Zn(didpa)Cl2 (10) (Eq. 2.11).76 
In order to determine the synthesis of the six-coordinate complex, the 1H NMR was monitored upon 
addition of 1.5 equivalents of NBu4SH (Figure 2.38). A significant change in the spectrum suggests that a 
reaction has occurred. There is a shift in the aromatic region of the spectrum due to a change in 
environment of the diisopropylphenyl group. There is also a shift in the diisopropyl protons from the 
pendant amine similar to the 1H NMR spectrum of 6. This is an indication that the diisopropylamine is 
locked into position due to being wrapped up in an H-bond.  
Figure 2.38. 1H NMR spectra of [Zn(didpa)Cl2SH]- before the addition of NBu4SH (top, black) and after the 




In order to show the reactivity and coordination with HS-, a UV-Vis titration was performed. The UV-Vis 
spectrum shows that upon addition of tetrabutylammonium hydrosulfide (NBu4SH), we see a decrease in 
intensity at the 313 nm peak and a new peak growing in at 282 nm. The spectrum also illustrates an 
isosbestic point at 296 nm, suggesting that there are only two species in solution. The Job plot tells about 
the binding ratios and is consistent with a 1:1 binding of HS- to the [Zn(didpa)Cl2] complex. To further 
verify that the Zn is capable of binding another group, tetrabutylammonium hydroxide pentahydrate was 
added in 0.1 equivalent increments and a UV-Vis spectrum was obtained after each addition (Figure 2.39). 
Up to 3 equivalents were added to the Zn(didpa)Cl2 solution. In order to analyze the binding activity of the 
hydroxide to the complex, a Job plot was obtained by analysis of UV-Vis. The didpa complex was 
introduced with tetramethylammonium hydroxide pentahydrate in MeCN at a total concentration of 413 
µM.  
 
Figure 2.39. Left: Titration of Zn(didpa)Cl2 (87.3 µM, CH2Cl2, black) with NBu4SH (0.1 equiv. increments up 
to 6 equivalents, red). Inset: Job plot consistent with 1:1 binding; Right: Titration of Zn(didpa)Cl2 (85.5 µM, 
CH2Cl2, black) with tetramethylammonium hydroxide pentahydrate). Inset: Job plot consistent with 1:1 
binding. 




















 Similarly, addition of OH- yields a 1:1 binding after plotting the Job plot. It is proposed that the OH- binds 
to the [Zn(didpa)Cl2] complex, generating a six-coordinate zinc complex (Figure 2.40). To further support 
that a six-coordinate zinc complex is forming as opposed to a simple subsitution of the substrate, a 
titration with a chloride source was performed. In the same way, titration of Zn(didpa)Cl2 with excess Cl-  
was analyzed through UV-vis and exhibited the same behavior as in the case of titration with SH- and OH-  
(see Figure S24). A disappearance of one peak and growing in of the other which is proposed to be the 
six-coordinate Zn(II) species (Figure 2.39) is observed in the UV-Vis spectrum.  
Figure 2.40. Proposed structures of the six-coordinate Zn(didpa) complexes upon addition of 
tetramethylammonium hydroxide pentahydrate (Me4NOH) [left] and tetrabutylammonium chloride 
(NBu4 Cl) [right]. 
 Unfortunately, no crystals were obtained despite the various use of chloride sources and solvent systems. 
Due to the reversibility of the process. In order to determine the stability of the [Zn(didpa)Cl2SH]- complex, 
the 1H NMR spectrum was interrogated. Low temperature NMR spectra were obtained in order to 
investigate the structural flexibility of the scaffold and the presence of the coordinated hydrosulfide 
(Figure S25, supporting information). As the sample is cooled, the HS resonance starts to appear in the 1H 
NMR spectrum. Upon cooling the sample to -35  ˚C in CD3CN, the HS resonance is shifted far downfield to 
11.05 ppm, suggesting that there is an NH hydrogen bond present in the sample. This was a feature 
observed in 1H NMR of the [Zn(Hdidpa)Cl2][PF6] complex as a result of H-bonding to the nitrogen from the 
pendant amine. This downfield shift observed was a result of the diisopropylamine serving as an H bond 
acceptor, accepting its H bond from the Zn-SH moiety. The ethylene bridge resonance at 3.6 ppm is 
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narrowed upon cooling the sample down. Similarly to complex 6, an N-H stretch is not observed in the 
FTIR spectrum, commonly seen in many H-bonding systems.28 
To confirm the requisite of an internal hydrogen bond in the complex, a previously sythesized zinc PDI 
complex containing no pendant base in the secondary coordination sphere was exposed to the same 
treatment as [Zn(Hdidpa)Cl2][PF6] (6).  Addition of 0.5 equivalents of NBu4SH to the compound resulted in 
the formation of a white precipitate (Eq. 2.12). It was determined that the precipitate formed was zinc 
sulfide. Reaction of Bis-PDI with NBu4SH shows decomposition, demonstrating the importance of the H-




The synthesis of and characterization of various Fe(II) and Zn(II) complexes using the pyridinediimine 
ligand, didpa, have been utilized in order to probe the role of the secondary sphere. The intramolecular 
hydrogen bonding ability that the didpa ligand scaffold possesses has allowed us to explore the metal 
halogen hydrogen bonds (MHHBs) in zinc complexes, redox activity in iron complexes, and the 
stabilization of a six-coordinate zinc complex via H-bond acceptance. The MHHBs in [Zn(Hdidpa)Cl2][PF6] 
(6), [Zn(Hdidpa)Br2][PF6] (7) and [Fe(Hdidpa)Cl2][PF6] (8), and [Fe(Hdidpa)(CO)2][PF6] (10) were 
determined by X-ray crystallography. The strength of the MHHBs were determined in both the solid-
state as well as in solution.  Additionally, the pKa was determined to remain unaffected relative to the 
pKa of Hünig’s Base (pKa=18.8). The redox activity of the didpa ligand was also explored using 
Fe(didpa)(CO)2 (9) and [Fe(Hdidpa)(CO)2][PF6] (10), resulting in a 105 mV upon protonation of the 
secondary coordination sphere. Given that the didpa ligand scaffold had the ability to stabilize MHHBs 




donor in the neutral form, the zinc hydrosulfido complex was synthesized. Analysis of UV-Vis spectra for 
the six-coordinate zinc complexes was used to confirm the synthesis [Zn(didpa)Cl2SH]- upon addition of 
NBu4SH.  
Chapter 3. Redox Inactive Metals 
3.1 Incorporation of Redox Inactive Metals  
The incorporation of various redox inactive metal ions is essential in many biological and biomimetic 
electron transfer reactions.37,77 In nature, the utilization of a redox-inactive metal is demonstrated by 
the conversion of water to oxygen carried out by the oxygen evolving complex (OEC) in photosystem 
II.36a The redox inactive Ca ion is crucial for catalysis and without it, the OEC is virtually inactive.36a,78 The 
calcium ion participates in the binding and activation of a water substrate, as well as the proton coupled 
electron transfer of the cluster.  During this process, the OEC undergoes 4 electron transfer events 
which in turn leads to a high oxidation state manganese cluster. In this high oxidation state, the Mn 




Figure 3.1. Depiction of the OEC, displaying the “cubane-like” structure of the Mn4CaO5 cluster.  
In a non-biological setting, this is observed in the water oxidation catalyzed by heterogeneous cobalt 
and manganese oxides containing alkali or alkali earth metals.80-83 These bio-inspired catalysts are 
responsible for water oxidation and mimics the cubane-like architecture recognized from the native 
oxygen evolving complex (OEC) active site. Redox inactive metals can also play a role in dioxygen 
activation84, peroxide activation85, H-H bond cleavage86, O- and H- atom transfer87, and alkane 
oxidation.79, 88 Considering the participation of redox inactive metal ions in electron transfer reactions, 
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many synthetic models have been synthesized containing attributes that mimic those of the native OEC. 
Metal ions that can function as Lewis acids are often combined with redox active metals in order to 
promote a variety of reactions involving the transfer of electrons.77a  
Borovik and coworkers have demonstrated that incorporating redox-inactive metal ions in the 
secondary coordination sphere of their MnII complex enhances the rates of O2 reduction.77a Specifically, 
the presence of group 2 metal ions has allowed for this rate enhancement. The structural design of the 
the sulfonamido-based tripodal system contains SO2AR groups acting as H-bond acceptors (Figure 
3.2).77a  The oxygen atoms of these SO2AR groups are capable of binding group the redox-inactive metal 
ions in order to accelerate the dioxygen activation process. Similar to the native OEC, there is a 
dependence on the presence of redox-inactive metals for the rate of O2 activation. It was noted that 














Figure 3.2. Structural construct of the tripodal ligands containing H-bond acceptors; sulfonamindo based 
tripodal system presenting a manganese center and a calcium ion in the secondary coordination sphere, 




A way to control catalytic activity and selectivity is the use of non-covalent cation-crown interactions. 
Miller and coworkers were able to incorporate a redox inactive metal in their pincer scaffold containing 
an aza-crown ether moiety, which promotes cation reactivity near the active site of the metal ion (Figure 
3.3). The cation is capable of tuning the chemical reactivity by aiding in the binding of low coordinate, 
reactive intermediates as well as offering a mechanistic pathway for catalysis acceleration through acid-
promoted steps upon addition of the Lewis acid. The pincer crown ether ligand can act as a gate for 
substrate binding for catalytic reactions. The series of these iridium complexes with the ability to 
coordinate Lewis acidic metal cations can be used to explore small molecule activation.86,90 
Figure 3.3. Iridium carbonyl complex containing an aza-crown ether macrocycle capable of cation-crown 
interactions (left) and pincer crown ligand scaffold with the addition of Na+ to the system. 86,90 
As was discussed in Chapter one, Agapie and coworkers have synthesized heterometallic clusters in 
which a redox inactive metal ion can be incorporated in order to study the effect on the electronic 
properties of the complex.77b,79 A series of high oxidation state tetranuclear-dioxido clusters and with 
varying redox inactive metal ions were investigated by cyclic voltammetry. Heterometallic mangansese-
oxido clusters and heterometallic triiron-oxido clusters were synthesized in order to systematically 
investigate the redox potential of the complexes by varying the redox-inactive metal ions. The results of 
the electrochemical studies of these complexes showed that there was a linear correlation between the 
reduction potential and the pKa of the metal, suggesting the importance of metal ions in modulating the 
redox potential of the clusters.37b  
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Inspired by previously developed systems in which redox-inactive metals are incorporated, our group 
wanted to merge the idea of Lewis acids in the secondary coordination sphere in conjunction with the 
redox-active PDI scaffolds in order to modulate the redox activity of the system. By appending a crown 
ether in the secondary coordination sphere, we are able to chelate a redox-inactive metal ion (Lewis 
acid) in the cavity of a pendant 15-crown-5 (Figure 3.4).91 The effect that the encapsulated alkali metal 




Figure 3.4. FeII PDI complex capable of chelating a redox inactive metals in the crown ether (M= Na+, Li+). 
3.2 Synthesis of 15c5PDI Complexes  
The asymmetric PDI ligand [(ArN=C(CH3))C2H3N((CH3)C=O] and FeCl2 were dissolved in approximately 20 
mL of ethanol into a 100 mL round bottom Schlenk flask with a stir bar. The solution was heated to 80 C 
for 15 min under N2 gas and stirred. A solution of 2-aminomethyl-15-crown-5 in 10 mL of ethanol was 
slowly syringed into the flask and the solution was heated for 12 h under N2 gas (Eq. 3.1). The solvent 
was removed in vacuo and a dark blue solid was obtained. Back in the glovebox, the resulting solid was 
redissolved in 5 mL of CH2Cl2 and filtered through Celite into a 20-mL scintillation vial. The filtrate was 
layered with pentane and set aside to allow for crystallization. Blue crystals identified as Fe(15c5PDI)Cl2 





The solid-state structure was mostly unresolvable due to severe disorder in the 15-c-5, however, the 
general view of the preliminary structure (Figure 3.5) shows that the Fe center is five-coordinate.   
 
Figure 3.5. General view of complex Fe(15c5PDI)Cl2 (11), illustrating the disorder from the 15-c-5. 
The Mössbauer parameters obtained included the quadrupole splitting (ΔEQ) and isomer shift (δ), 0.949 
(8) mm/s and 0.824 (5) mm/s respectively. These Mössbauer parameters confirm the high spin FeII 
center (Figure 3. 6).92
 
Figure 3.6. Room temperature zero-field Mössbauer spectrum of Fe(15c5PDI)Cl2 (11). 


























3.3 Reduction of 15c5PDI Complexes 
The dichloride species was dissolved in DCM and reduced under 20 psi CO in order to produce the 
dicarbonyl iron species (Eq. 3.2).  Slow evaporation of diethyl ether yielded dark green crystals identified 
as Fe(15c5PDI)(CO)2 (12). 
  
The solid-state FTIR illustrates the appearance of two stretches at 1946 cm-1 and 1882 cm-1, 
corresponding to the CO stretches from complex 12 (Figure 3.7).  
 
Figure 3.7. Solid-state FTIR spectrum of Fe(15c5PDI)(CO)2 (12). 
 
The 1H NMR spectrum (Figure 3.8) reveals the C-H resonances from the 15-c-5 pendant crown are found 
in the range from 3.5 ppm to 4.5 ppm. At 1 ppm, we observe the resonances from the protons 
corresponding to the isopropyl group of the 2,6-diisopropyl aryl group. The aromatic protons from that 


















Figure 3.8. 1H NMR of Fe(15c5PDI)(CO)2 (12), 500 MHz, CD3CN (* represents solvent). 
 
The solid-state structure of 12 (Figure 3.9, left) reveals a square pyramidal geometry (τ = 0.04).93 The 
Cimine-Nimine bonds measured as 1.333(5) and 1.323(5) Å. The Cimine-Cipso bonds measured to be 1.431 (5) 
and 1.444 (5) Å. The Mössbauer parameters (ΔEQ= 1.198 (7) and δ= -0.080 (2) mm/s) suggest a spin state 
of S = 0 with a FeII center and a doubly reduced 15c5PDI ligand.92 The Mössbauer spectrum is shown in 
Figure 3.9, right. Table 3.1 summarizes the Mössbauer parameters for 12, 13, and 14.  
Figure 3.9.  Solid-state structure (30% probability) of Fe(15c5PDI)(CO)2 (12) (left) and zero-field room 
temperature Mössbauer spectrum of Fe(15c5PDI)(CO)2 (12) (right). Selected bond lengths (Å) and angles 


























(deg): Fe1–C34 1.784(4), Fe1–C33 1.787(5), Fe1–N1 1.964(3), Fe1–N2 1.857(3), Fe1–N3 1.965(3), C2–N1 
1.333(5), C8–N3 1.323(5); C34–Fe1–C33 95.56(19), N2–Fe1–C33 153.18(17), N1–Fe1–N3 155.54(13). 
Table 3.1. Mössbauer parameters for and selected bond lengths for 12, 13, 14. 
 12 13 14 
ΔEQ (mm/s) 1.198 (7)   
δ (mm/s)  
Cimine-Nimine (Å)    
Cimine-Cipso (Å)    
 
3.4 Encapsulation of Li+   
A slight excess of Lithium hexafluorophosphate (LiPF6) was added to a dark green solution of 
15c5PDIFe(CO)2 (12) in acetonitrile and allowed to stir for one day. The solvent was removed in vacuo and 
redissolved in CH2Cl2. The filtered CH2Cl2 solution was layered with pentane to produce dark green 
crystals were identified as [15c5PDIFe(CO)2Li][PF6] (13) (Eq. 3.3). 
 
The FTIR spectrum displayed the carbonyl stretches at 1931 and 1866 cm-1 (Figure 3.10). However, in 
solution a shift is observed in the carbonyl stretches to 1951 and 1886 cm-1. The PF6- counterion shows 




































Figure 3.10. Solid FTIR spectrum of [15c5PDIFe(CO)2Li][PF6] (13).  
The 1H NMR spectrum of 13 shows a fairly similar spectrum to that of 12 (Figure 3.11). However, upon 
encapsulation, a slight shift is observed in the crown protons from 3.04, 3.13, and 3.42 ppm in 12 to 
3.25, 2.28, and 3.49 ppm in 13. The expected triplet and doublet are overlapped into a multiplet 
integrating for the three protons. In complex 12 however, two very distinct resonances are observed for 
those protons.  




The solid-state structure  of 13 (Figure 3.12) established a five-coordinate Fe(II) center with square 
pyramidal geometry (τ = 0.36). The Cimine-Nimine bond lengths measured yielded values of 1.326 (6) and 
1.331 (6) Å. The Cimine-Cipso bond lengths remain the same (1.441 (7) and 1.434 (7) Å), confirming no 
change in the oxidation state of the ligand upon addition of the alkali metal ion (Table 3.1). The 
structure illustrates a six coordinate Li+, in which it interacts with the 5 oxygen atoms from the 15-c-5 
crown and one of the fluorine atoms from the PF6- counterion (Figure 3.12).  The Mössbauer parameters 
include EQ of 1.75(1) mm/s and δ of -0.080(5) mm/s shows a doubly reduced PDI ligand, further 
confirming no change in the oxidation state.  
 
Figure 3.12.  Solid-state structure (30% probability) of [15c5PDIFe(CO)2Li][PF6] (13) (left);  Zero-field room 
temperature Mössbauer spectrum of [15c5PDIFe(CO)2Li][PF6] (13)  (right). Selected bond lengths (Å) and 
angles (˚): Fe(1)-C(34) 1.777(6), Fe(1)- C(33) 1.777(6), Fe(1)-N(1) 1.975(4), Fe(1)-N(2) 1.842(4), Fe(1)-N(3) 
1.967(4), C(2)-N(1) 1.325(6), C(8)-N(3) 1.312(7), Li(1)-F(1) 1.860(10), Li(1)-O(3) 2.147(11), Li(1)-O(3) 
2.147(11), Li(1)-O(4) 2.318(12), Li(1)-O(5) 2.153(11), Li(1)-O(6) 2.104(12), Li(1)-O(7) 2.277(11), and 
C(34)Fe(1)C(33) 93.2(2), N(2)Fe(1)C(33) 128.9(2), N(1)Fe(1)N(3) 158.21(18). 
 
The complex was investigated in solution to further explore the interaction between the Li+ and the 15-
c-5. Titrations of Li+ in acetonitrile-d3 to a solution of 12 acetonitrile-d3 (Figure 3.13) were carefully 
examined through NMR spectroscopy. The C-H region of the 15-c-5 ring was monitored in order to 
observe its chemical shift upon encapsulation of the Li+. An average chemical shift of 0.125 ppm was 

























observed in the crown ether resonances of 15c5PDIFe(CO)2 (12) upon encapsulation of the Li+ metal ion. A 
plot of the chemical shift of the C-H group versus the equivalents of LiPF6 added to the solution 
demonstrated that there was a 1:1 binding ratio of complex to LiPF6. This observation is also reflected in 
the 1H NMR spectrum. After the addition of one equivalent of LiPF6, there is no resonance shift observed 
in the C-H region. 
 
Figure 3.13. Plot of the chemical shift of the 15c5 C-H resonances in 15c5PDIFe(CO)2 (12) versus the 
equivalents of LiPF6 added (left) and the stacked 1H NMR spectra corresponding to the 15c5 C-H 
resonances upon titration with LiPF6. (0 equivalents of LiPF6 [bottom] and 3 equivalents of LiPF6 added 
[top]).  
3.5 Encapsulation of Na+   
The 15c5PDIFe(CO)2 (12) complex can also chelate the Na+ metal ion. A slight excess of sodium 
hexafluorophosphate was added to a dark green solution of 12 in CH3CN and allowed to stir for one day 
(Eq. 3.4). The solvent was removed in vacuo and redissolved in CH2Cl2. The filtered DCM solution was 





The solid-state FTIR spectrum reveals the carbonyl stretches at 1936 and 1868 cm-1 (Figure 3.14). The 
PF6- counterion is present at 835 cm-1. In solution, a shift in the carbonyl stretches is also observed (1951 
cm-1 and 1886 cm-1). 
Figure 3.14. Solid-state FTIR spectrum of [15c5PDIFe(CO)2Na][PF6] (14). 
 
The solid-state structure (Figure 3.14, left) established a five-coordinate iron center with a square 
pyramidal geometry ( = 0.01). In this case, the Na+ is seven coordinate interacting with five oxygen 
atoms and two F atoms from the PF6- counterion. Upon encapsulation of the Na+ metal ion, the Cimine-
Nimine bond lengths yielded values of 1.333(5) and 1.323 (5) Å and Cimine-Cipso bond lengths of 1.441 (7) 
and 1.434 (7) Å (Table 1). These bond lengths did not change much from the Cimine-Nimine (1.326 (6) and 
1.331 (6) Å) and Cimine-Cipso (1.431 (5) and 1.444 (5) Å) measured in 15c5PDIFe (CO)2 (12), suggesting that 
there is no change in oxidation state of the ligand.  As determined by Mössbauer(ΔEQ= 1.418(9) mm/s 
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and δ= -0.087(5) mm/s), the iron center remains Fe(II) and the ligand is confirmed to be a doubly 
reduced 15c5PDI (Figure 3.14, right). 
Figure 3.15. Solid-state structure (30% probability) of [Fe(15c5PDI)(CO)2 Na][PF6] (14) (left). Room-
temperature Mössbauer of [Fe(15c5PDI)(CO)2 Na][PF6] (14). Selected bond lengths (Å) and angles (deg): 
Fe1–C34 1.795(6), Fe1–C33 1.792(6), Fe1–N1 1.980(4), Fe1–N2 1.863(4), Fe1–N3 1.972(4), C2–N1 
1.331(6), C8–N3 1.326(6), Na1–F1 2.438(4), Na1–F2 2.401(4), Na1–O(avg) 2.414; C34–Fe1–C33 97.5(2), 
N2–Fe1–C33 155.7(2), N1–Fe1–N3 153.79(16). 
Similar to the observations made between the 1H NMR spectra of 12 and 13, the 1H NMR of 14 results in 
a downfield shift in the C-H resonances from the 15-c-5 upon the encapsulation of Na+ (Figure 3.15). 
There is a slightly bigger shift observed upon encapulation of the Na+ metal ion (0.134 ppm shift in 14 
versus a 0.125 ppm in 13).  

























Figure 3.16. 1H NMR of of [15c5PDIFe(CO)2Na][PF6] (14); 500 MHz, CH3CN (* represents solvent). 
The C-H region of the 15-c-5 ring in complex 14 was investigated in solution through a series of titrations 
in order to determine the binding effect of the Na+ metal ion (Figure 3.16). An average shift of 0.134 
ppm is observed after the addition of one equivalent NaPF6. No further shift in the C-H crown proton 
resonances were observed after one equivalent NaPF6, suggesting that the Na+ metal ion was 
encapsulated in the crown ether. The plot of the chemical shift of the 15-c-5 resonances versus the 
equivalents of NaPF6 added to the complex demonstrates a 1:1 binding of the alkali metal ion, Na+.   
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Figure 3.17. Plot of the chemical shift of the 15c5 C-H resonances in 15c5PDIFe(CO)2 (12) versus the 
equivalents of NaPF6 added (left) and the stacked 1H NMR spectra corresponding to the 15c5 C-H 
resonances upon titration with NaPF6. (0 equivalents of NaPF6 [bottom] and 3 equivalents of NaPF6 
added [top]).  
 
3.6 Effect on Reduction Potentials 
The secondary coordination sphere has been shown to tune the redox potential of the metal center.94  In 
order to study the effect of the alkali ion on the reduction potentials, the electrochemistry of these 
reduced complexes was performed in three different solvents, THF, dichloromethane and acetonitrile.  
The results of the cyclic voltammetry in THF illustrated two quasi-reversible events observed 




Figure 3.18. Cyclic voltammograms of 15c5PDIFe(CO)2 (12), [15c5PDIFe(CO)2Li][PF6] (13), and 
[15c5PDIFe(CO)2Na][PF6] (14) in THF; 0.1 M TBAPF6, Ag/Ag+ reference electrode, glassy carbon working 
electrode, Pt counter electrode 
 
 These quasi-reversible events have been previously observed in PDI ligand systems.58, 95 However, when 
the electrochemistry is performed in acetonitrile, there are three redox events present (Figure 3.18). 
There are two irreversible events (-0.550 V and -1.20 V) and one reversible event (-2.303 V) observed in 
the cyclic voltammograms. One irreversible event is due to the one electron oxidation of the ligand to 
form [Fe(15c5PDI)(CO)2]+ and the second irreversible event is likely a result of acetonitrile binding. 
Figure 3.19. Cyclic voltammograms of 15c5PDIFe(CO)2 (12), [15c5PDIFe(CO)2Li][PF6] (13), and 
[15c5PDIFe(CO)2Na][PF6] (14) in Acetonitrile; 0.1 M TBAPF6, Ag/Ag+ reference electrode, glassy carbon 




 In DCM, however, the irreversible event present in the THF and MeCN samples is now reversible. This 
oxidative event in DCM has an E1/2 value of -0.602 V. Compared to 12, there is only about a 50 mV shift 
in the oxidation potential (Eox) and the reduction potential (Ered) when Na+ is added to the system. 
However, upon addition of Li+ to the system, the 50 mV shift is only observed in the Eox. The results of 
these experiments showed that we are able to have highly reduced complexes with a redox-inactive 
metal in the secondary coordination sphere which can then be used to perform other types of electron 
transfer reactions.  
In order to confirm the reversibility of these redox events, the reductive event versus the square root of 
the scan rate was plotted in both DCM and MeCN (Figure 3.19). The linearity of these plots supports the 
reversibility of these redox events.  
Figure 3.20. Cyclic voltammograms of 1mM Fe(15c5PDI)(CO)2 (12) (black), [Fe(15c5PDI)(CO)2 Li][PF6] (13) 
(red), [Fe(15c5PDI)(CO)2 Na][PF6] (14) (blue) in DCM (left) and in CH3CN (right); 0.1 M TBAPF6, Ag/Ag+ 
reference electrode, glassy carbon working electrode, Pt counter electrode; and their corresponding 
plot of reductive event, Ecathodic peak current versus square root of the scan rate for of Fe(15c5PDI)(CO)2 
(12) (red squares), [Fe(15c5PDI)(CO)2 Li][PF6] (13) (blue squares), [Fe(15c5PDI)(CO)2 Na][PF6] (14) (green 
squares).  











































































































It was determined that these highly modular PDI ligand scaffolds are capable of encapsulating redox-
inactive alkali metal ions (Li+ and Na+) both in solution and in solid state within the cavity of a pendant 
15-crown-5. The electrochemical studies of the PDI system upon encapsulation of the Li+ and Na+ ions 
have shown to only have modest shifts in redox sites of the complex. Due to the unchanged redox sites, 
these systems can now be used to participate in electron transfer reactions, such as those observed in 
biological and synthetic systems.  
Chapter 4. Dinitrosyl Iron Complex (DNIC) 
4.1. Reduction of nitrate and nitrite to nitric oxide 
Nitric oxide (NO) is versatile as a coordinating ligand due to its low ionization potential (9.5 eV) in 
comparison to other small molecules such as N2 (14.5 eV) or CO (14.1 eV).96 Nitric oxide’s role as a signaling 
molecule aids in regulating blood pressure in the cardiovascular systems as well as regulating blood flow. 
Biologically, NO targets metal sites such as iron-sulfur cluster proteins, leading to the formation of 
dinitrosyl iron complexes (DNICs).97,98 DNICs play a role in the transport of NO to molecules such as 





Figure 4.1. The heme site of the structure of the MbChl(NO2) compound.99 (Figure made in PyMOL). 
Nitric oxide is considered a redox active ligand and is capable of binding in 3 distinct forms: NO·, NO+, or 
NO-. The NO ligand is treated as NO+ in a case where the M-N-O bond is about 180˚, whereas an angle less 
than 180˚ (bent) will yield to a treatment of NO-. In order to describe the M-NO moiety in transition metal 
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nitrosyl complexes, the Enemark-Feltham notation, {M(NO)x}n, is used. In this notation, the n is the total 
number of metal d and NO π* electrons and x is the number of NO ligands bound to the metal (M) 
center.100 The use of this notation allows for the electron count of this moiety to remain consistent, 
regardless of how the NO ligands are treated.   
In order to explore the reduction of nitrate (NO3-) and nitrite (NO2-) to NO, we have developed complexes 
capable of mimicking the biological production of NO. Iron(II) PDI complexes with pendant bases in the 
secondary coordination sphere were synthesized. The redox-active PDI ligand scaffold, is capable of being 
protonated in the secondary coordination sphere and can therefore be used as the source of both protons 
and electrons for the transformation. Given that both the reduction of nitrate to NO (NO3- + 4H++ 3e- 
NO + 2H2O; ΔE = 0.96 V) and nitrite to NO (NO2- + 2H++ e- NO + 2H2O; ΔE = 0.35 V)101 require protons 
and electrons for the transformation to occur, the PDI complexes make ideal candidates to probe these 
reductions.  
4.2. DNIC Complexes 
It was previously determined that the [Fe(HDEAPDI)(CO)2][PF6]  (where DEAPDI=[(2,6-
iPrC6H3)(N=CMe)(N(Et)2C2H4)(N=CMe)C5H3N]) complex can be used to synthesize the DNIC, 




The doubly reduced complex with a protonated secondary coordination sphere, [Fe(HDEAPDI)(CO)2][PF6], 
is capable of the transfer of both protons and electrons. Taking advantage of the presence of both protons 
and electrons in the PDI system, nitrite reduction to NO was probed, leading to the synthesis of the DNIC.  
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Given the similarities of the DEAPDI ligand to the didpa ligand, we postulated that the DNIC complex could 
also be synthesized using the didpa ligand scaffold. For example, much like the didpa species, the DEAPDI 
ligand also undergoes a 105 mV shift upon protonation of the pendant amine.102bThese two ligand 
platforms also share near identical architecture with the pendant base of the didpa ligand having a pKa of 
18.4 and the diethylamine a pKa of 18.1 upon being appended to the PDI scaffold. The CV properties of 
the DEAPDI ligand and the didpa scaffold are summarized in Table 4.1. For this reason, the didpa complex 
seemed viable to use for probing the reduction of NO2- to NO.  
Table 4.1. Summarized CV events of DEAPDI (pKa= 18.1) and Didpa (pKa= 18.4). 
 DEAPDI Ligand Didpa ligand 
Unprotonated E1/2 (V) -0.579 -0.590 
Protonated E1/2 (V) -0.474 -0.485 
Δ E1/2 (mV) 105 105 
 
4.3 Synthesis of [Fe(HDEAPDI)(CO)2][PF6] 
In order to synthesize [Fe(didpa)(NO)2] +, a solution of NaNO2 in MeOH was added to a green THF solution 
of [Fe(Hdidpa)(CO)2][PF6] (10) (Eq. 4.2).  The solution was stirred for overnight before being filtered 
through Celite. A color change from a dark green to a red-brown solution suggested that a reaction had 
occurred. Layering of the THF filtrate with pentane led to red-brown crystals identified as 





The solid-state FTIR spectrum of the DNIC 15 illustrates the absence of the 1940 cm-1 and 1883 cm-1 CO 
stretches from 10 and the appearance of the NO stretches at 1789 cm-1 and 1716 cm-1 (Figure 4.2). These 
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results confirm the complete reaction of the CO species, as the CO stretches are no longer present. The 
NO stretches are similar to those in the [Fe(DEAPDI)(NO)2]+ complex found at 1786 cm-1 and 1716 cm-1.102,103 
The NO stretching frequencies are also around the same values as observed in other synthesized 









Figure 4.2. Solid-state FTIR spectra of [Fe(Hdidpa)(CO)2][PF6] (10) (blue line) illustrating the CO stretches 
and of [Fe(didpa)(NO)2][PF6] (15) (red line) illustrating the NO stretches.  
 
The 1H NMR spectrum of 15 illustrates significant changes from 10. In comparison to the spectrum of 10, 
we observe less well-defined resonances (Figure 4.3). 









































Figure 4.3. 1H NMR spectrum of the [Fe(didpa)(NO)2][PF6] (15); 500 MHz, CH2Cl2. 
The solid-state structure of 15 is shown in Figure 4.4, confirming the synthesis of the DNIC. The geometry 
obtained from the crystal structure of 15 was found to be square pyramidal ( = 0.26). The Cimine-Cipso bonds 
are measured to be 1.329 and 1.336 Å. The Cimine-Nimine bonds in 15 are contracted from 1.317 (2) and 
1.329 (3) Å in [Fe(Hdidpa)(CO)2][PF6] (10) to 1.271 Å and 1.282 Å in 15. This decrease in bond lengths of 
the Cimine-Nimine bonds suggests that the system is no longer doubly reduced. The Mössbauer spectrum of 
15 was obtained, yielding an isomer shift of 0.348(5) mm/s and an EQ = 0.791(7) mm/s (Figure 4.4). As was 
proposed from the contraction of the Cimine-Nimine bonds and the elongation of the Cimine-Cipso bonds, the 
oxidation state confirms a neutral ligand. These conclusions can be further supported by analyzing the 







Figure 4.4. Solid-state structure (30% probability) (left) and the Mössbauer spectrum (right) of 
[Fe(didpa)(NO)2][PF6] (15). The PF6- counterion is omitted for clarity. Selected bond lengths (Å) and angles 
(deg): Fe-N2 2.227, Fe-N3 2.145, Fe-N5 1.689, Fe-N6 1.688, N6-O2 1.163, N5-O1 1.154, C2-N3 1.271, C1-
N2 1.282, Fe-N5-O1 162.5 (3), Fe-N6-O2 163.6 (2), N2-Fe-N3 148.28. 
 
The calculated average Fe-NO bond angle obtained from the solid-state structure was 163.1 (bent).  The 
average bond length for Fe-NO in 15 is 1.698 Å, which correlates well with those of other characterized 
DNIC systems (Table 4.2).102,103,104 As was observed from the DEAPDI system, we can assign 15 an Enemark-
Feltham notation of {Fe(NO)2}9 as well. As was previously calculated, the Fe is treated as a neutral (d8) 
metal center with each bound NO ligand donating 1 electron, adding to 10 total electrons. However, we 
must recall that the overall charge of the complex is +1, yielding nine total electrons. Similar Enemark-
Feltham notations have been reported by other groups who have synthesized these DNICs.  
Table 4.2. Comparison of DNIC parameters.102,103,104 
Complex 𝑣NO (cm-1) Fe-N(O) (Å) N-O (Å) δ(mm/s) ΔEQ (mm/s) 
[Fe(didpa)(NO)2]+ 1789, 1716 1.689 1.159 0.348 (5) 0.791 (7) 
[Fe(DEAPDI)(NO)2]+ 1786, 1716 1.688 1.173 0.308 (7) 0.89(1) 
[Fe(iPrPDI)(NO)2]+ 1794, 1721 1.704 1.169 - - 
[Fe(dmp)(NO)2]+ 1746, 1840 1.674 1.174 0.37 1.77 
[Fe(NHC-iPr)2(NO)2]+ 1723, 1791 1.696 1.177 0.11 0.27 
                 (*dmp= 2, 9-dimethyl-1,10-phenanthroline; NHC= N-heterocyclic carbenes) 


























In order to verify that the bound NO ligands came from the nitrite source, as opposed to an external 
source, an isotopic study was performed. The isotopic form of sodium nitrite (Na15NO2) was obtained and 
the reaction with 10 was carried out following the synthesis from (Eq. 4.2). Analogous to the synthesis 
with Na14NO2, we observe the color change from green to red brown. Analysis of the solid-state ATR-FTIR 
spectrum illustrates the NO stretching frequencies of 15(15NO)2 alongside the NO stretches from the 
15(14NO)2 synthesis. There is a distinct shift in the NO stretching frequencies from the 14NO and the 15NO. 
A shift from 1789 cm-1 and 1716 cm-1 in 15(14NO)2 to 1755 cm-1 and 1684 cm-1 in 15(15NO)2 can be seen as 
a result of the isotopic mass difference. These values correlate well to the expected shift values of 1757 
cm-1 and 1685 cm-1 calculated based on the reduced mass.  
Figure 4.5. Solid-state FTIR spectra of 15(14NO)2 (blue line) and 15(15NO)2 (red line), illustrating the NO 
stretches. 
4.4. Electrochemistry of [Fe(didpa)(NO)2][PF6] 
In order to understand the redox properties of 15, the electrochemistry of the complex was investigated 
by cyclic voltammetry. This was performed under N2 atmosphere in CH3CN using 0.1 M 
tetrabutylammonium hexafluorophosphate [(nBu)4N][PF6] as the supporting electrolyte, glassy carbon 
working electrode, platinum counter electrode, and a Ag/Ag+ reference electrode. The CV of 15 reveals 



























4.6). It can be proposed that the two observed reversible events are ligand-based reduction events, given 
that the open circuit potential (OCP) of complex 15 yielded a value of -0.360 V. 
 
Figure 4.6. Cyclic voltammogram of 0.010 M [Fe(didpa)(NO)2][PF6]; 0.1 M [(nBu)4N][PF6] in CH3CN, 200 
mV/s scan (glassy carbon working electrode, platinum counter electrode, and a Ag/Ag+ reference 
electrode). 
 
In order to determine the reversibility of the redox events, reversibility studies were performed at each 
redox event. The results (Figure 4.7) confirm the reversible process in acetonitrile which can be seen in 
the plot of the Ecathodic peak current versus square root of the scan rate for 15.  
Figure 4.7. Cyclic voltammograms of 0.010 M [Fe(didpa)(NO)2][PF6] at E1/2= -0.910 V (left) and E1/2= -1.185 
V (middle); 0.1 M [(nBu)4N][PF6] in CH3CN; 200 mV/s scan rate. Far right: Plot of Ecathodic peak current versus 
square root of the scan rate for [Fe(didpa)(NO)2][PF6] (15) at E1/2= -0.910 V (black line) and E1/2= -1.185 V 
(blue line), showing a linear correlation, to confirm the reversible process in CH3CN. 
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4.5. Synthesis of [Fe(didpa)(NO)2][PF6] via Nitrate Reduction 
The synthesis of the DNIC was also obtained by the addition of one equivalent of tetrabutylammonium 
nitrate (TBANO3) to a THF solution of 10 (Eq. 4.3) into a pressure vial.  The solution was placed in an 80 C 
oil bath for 12 hours before being filtered through a Celite plug.  A color change from green to a dark red-
brown solution was observed, suggesting a reaction had occurred.  
 
 
Both a liquid and a solid IR spectrum was obtained in order to determine the products of the reaction 
(Figure 4.8, left). The results of the IR spectra confirmed the synthesis of the DNIC complex. Various 
solvent systems are still under investigation to try and obtain a crystal of the complex in order to 
investigate the solid state structure and confirm the synthesis of the DNIC complex. The liquid IR spectrum 
of the synthesized complex (Figure 4.8, right) also illustrates the absence of the carbonyls and the 
presence of the bound NO. 
Figure 4.8. Solid-state FTIR (left) and liquid IR (right) spectra of [Fe(Hdidpa)(CO)2][PF6] (blue/ black line) 
illustrating the CO stretches and the proposed DNIC (red line) after reaction with TBANO3, illustrating the 
NO stretches. 













4.6. FTIR Isotopic Labeling 
Isotopic studies for the reduction of nitrate with [Fe(Hdidpa)(CO)2][PF6] (10) were performed using 
TBA15NO3 as the NO3- source in an 80 C oil bath. The resulting solution showed a color change from green 
to red-brown. Analysis of the FTIR spectrum shows a shift of the NO stretches from 1785 cm-1 and 1713 
cm-1 to 1750 and 1700 cm-1 (Figure 4.9).  






































Figure 4.9. Solid-state FTIR spectra of [Fe(didpa)(NO)2][PF6] (15) with TBA14NO3 reaction (red line) and 15 
with TBA14NO2 (blue line), illustrating the NO stretches and the isotopic shift. 
 
A comparison in the solid-state IR spectrum of the newly synthesized complex to 15 further supports the 




Figure 4.10. Solid-state FTIR spectra of [Fe(didpa)(NO)2][PF6] (15) (blue line) and the proposed DNIC (red 
line) after reaction with TBANO3, illustrating the NO stretches. 
4.7. Effects of temperature on the synthesis of [Fe(didpa)(NO)2][PF6]  
In order to demonstrate that heat is necessary for synthesis of the DNIC, the reaction from 4.3 was run at 
room temperature. The resulting products were analyzed via the solid-state and liquid IR spectra (Figure 
S26 and S27). However, upon inspection of the IR, the CO stretches from compound 10 are still present, 
suggesting that no reaction occurred between complex 10 and TBANO3 and that reduction of NO3- requires 
heat for the reaction to proceed. A solid-state IR was obtained to determine if a reaction had occurred.  
However, the IR spectrum showed the presence of the CO’s from the complex and no other changes were 






















































Figure 4.11. Solid-state FTIR spectrum of [Fe(HdidpaI)(CO)2][PF6] (10) with the addition of TBANO3 in THF 
after one day of stirring at room temperature.  
 
Considering the possible decomposition of the reactants upon heating to 80 C, it was important to 
explore the stability of TBANO3 in 80 C temperature. TBANO3 was dissolved in THF and transferred to a  
20 mL pressure vial and heated overnight at 80 C. The solvent was removed and a solid-state IR was 
obtained. Comparing the heated solution to the solid-state IR of the TBANO3 salt at room temperature 
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Figure 4.12. Solid-state FTIR spectra of TBANO3 at room temperature (red line) and after being exposed 
to 80 C heat for one day (blue line).  
 
4.8. Investigating the role of the secondary coordination sphere in nitrate reduction 
In order to probe the role of the secondary coordination sphere of the didpa ligand scaffold, the 
direduced, unprotonated complex Fe(didpa)(CO)2 (9), was explored. The reaction of TBANO3 and 
Fe(didpa)(CO)2 (9) was set up (Eq. 4.4).  
The solid- state FTIR was obtained and the presence of the CO stretches from complex 9 demonstrated 
that no reaction had occurred when using 9, which lacks an H-bond in the secondary coordination.  
To further support this observation, the previously synthesized Fe(MeOPDI)(CO)2 complex was utilized as it 
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to a THF solution of Fe(MeOPDI)(CO)2 resulted in a dark green solution. The solution was placed in an 80 C 
oil bath for one day (Equation 4.5). Upon initial inspection of the reaction, there was no color change 
observed as we saw in the reaction from 4.3.  
 
The liquid IR spectrum was obtained and compared to that of 15 in order to resolve whether the dinitrosyl 
complex was synthesized. The results suggested that the DNIC was in fact not formed. Upon the 
introduction of an external proton source, protonated Hünig’s base [HDIPEA][PF6-], a color change 
occurred. However, it was concluded that the dinitrosyl complex was not synthesized based on the 
differences in the IR spectra. 
 
Figure 4.13. Liquid IR of Fe(MeOPDI)(CO)2 after addition of TBANO3 and [HDIPEA][PF6-] in THF at 80 C (red 
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4.9. Investigation of the products in the synthesis of [Fe(didpa)(NO)2][PF6] 
The yield of the DNIC complexes were calculated utilizing liquid IR. The small scale of the reactions allowed 
for a yield calculation using a calibration curve obtained from the NO stretches from the DNIC complexes. 
In a typical experiment, a series of solutions of known concentration of the DNIC were made up using THF 
as the solvent. The liquid IR spectrum was obtained for each individual solution using CaF2 cell plates in 
the IR cell. The absorbance corresponding to the NO peak allowed for the fitting of two separate 
calibration curves (Figure 4.14).  
Figure 4.14. Calibration curve of the NO peaks (1789 cm-1 and 1721 cm-1) for the % yield calculation of 
[Fe(didpa)(NO)2][PF6] (15).  
 
 A new liquid IR was obtained of a known concentration of the DNIC in THF, and using the calibration 
curves, the moles of 15 were obtained. The reduction of NO2- to NO using the didpa scaffold produced a 
39% yield of the DNIC. In comparison, the DEAPDI complex demonstrated a 52% yield. The reduction of 
NO3- to NO by use of the didpa complex gave a yield of 20%. The yields are summarized in Table 4.3. The 









In an effort to investigate the remaining products for the TBANO3 (Equation 4.3), the headspace analysis 
was analyzed for NO gas that may have been produced during the reaction. This was performed in a gas 
cell and studied via gas IR. The results did not exhibit NO peaks in the IR spectrum (Figure 4.15) and it 
established that NO gas is not a product of this reaction.  
Figure 4.15. Gas IR spectrum of the headspace in reaction of 10 with TBANO3 at 80 C. 
Since NO gas was not found in the headspace of the reaction, it was proposed that any excess nitrogen 
would be found as nitrate or nitrite in the remaining products. However, the solid-state FTIR spectrum 
gave inconclusive results, directing us to turn to ion chromatography.  
An aqueous extraction of the DNIC solution in THF was done using a 1 M Na2SO4 solution. The aqueous 
solution was analyzed for possible NO2- or NO3- ions. The results of this experiment (Figure 4.16) illustrated 
a peak at a retention time of 4.2 minutes, corresponding to NO3-. However, there was no peak observed 
in the NO2- region of the spectrum. We can then assume there is an excess in NO3- from the TBANO3 which 
did not react completely. The transformation of NO3- to NO requires the use of four protons and three 
Complex % Yield 
[Fe(DEAPDI)(NO)2]+ 52% 
[Fe(didpa)(NO)2]+ via NaNO2 39% 
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electrons (NO3- + 2H++ 2e- NO2- + 2H2O and NO2- + 2H++ e- NO + 2H2O). Therefore, it is expected that 
there is NO3- that will remain unreacted to NO due to the lack of electrons available in the PDI system. 
Upon protonation of the doubly reduced species, the solid-state structure and electrochemistry shows an 
availability of two electrons per PDI unit present for the reduction of nitrate. This limits the amount of 
NO3- that will fully reduce to NO, given that the full transformation is in need of three electrons. The 
spectrum obtained from the ion chromatography studies clearly shows the NO3- peak which can account 
for the unused NO3- based on the stoichiometry of Equation 4.3. Using the information obtained from the 
ion chromatograph, the amount of NO3- that is left unreacted can be calculated to be 34%.  
Figure 4.16. Ion chromatograph of the aqueous extraction of the reaction of [Fe(Hdidpa)(CO)2][PF6] (15)  
after addition of TBANO3 at 80 C, illustrating the presence of NO3- at 3.789 minutes (purple line) vs the 
standard containing F- at 1.9 min, Cl- at 2.6 min, and 15 ppm NO3- at 3.8 min (blue line). A standard of 



















Nature uses metalloenzymes for the activation of small molecules into more useful compounds. The 
motifs around the metal active site of metalloenzymes play a vital role for its function.  Many of these 
reactions require protons and electrons for the transformation to occur.  This thesis focuses on 
examining the secondary coordination sphere and merging that with the redox activity of metal 
complexes. The redox-active didpa ligand scaffold was used to synthesize Zn(didpa)Cl2, 
[Zn(Hdidpa)Cl2][PF6], Fe(didpa)Cl2, [Fe(Hdidpa)Cl2][PF6], Fe(didpa)(CO)2, [Fe(Hdidpa)(CO)2][PF6], 
[Zn(didpa)Cl2SH]- and [Fe(didpa)(NO)2][PF6] . The pendant amine in the didpa ligand allows for 
protonation in the secondary coordination, forming intramolecular hydrogen bonds that can aid in 
stabilizing substrates.  
A series of Zn(II) complexes were synthesized and characterized by means of X-ray 
crystallography, 1H NMR and FTIR. The protonated pendant amine of the didpa ligand in the zinc 
complexes allowed us to study the secondary coordination sphere of our system. The pKa of the ZnCl2 
complex was determined to be 18.1 and demonstrated that the pKa of the pendant amine does not get 
attenuated when the ligand is bound to the metal center of the complex. When protonated, 
[Zn(Hdidpa)Cl2][PF6] is able to form MHHBs. The strength of the MHHBs were determined by examining 
the results upon introduction of various H-bond accepting solvents and through gas phase calculations. 
The MHHB strength was computed to be 6 kcal/mol in Zn(didpa)Cl2 and 5 kcal/mol in Zn(didpa)Br2. The 
didpa ligand not only functions as an H-bond donor, but can also function as an H-bond acceptor. 
Considering this aspect of the ligand scaffold, the six-coordinate zinc hydrosulfido complex was 
synthesized. Analysis of UV-Vis spectra for the six-coordinate zinc complexes was used to confirm the 
synthesis [Zn(didpa)Cl2SH]- upon addition of NBu4SH, stabilized through the H-bond acceptance of the 
unprotonated didpa ligand.  
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In order to examine the redox activity of the didpa complexes, Fe(didpa)Cl2, [Fe(Hdidpa)Cl2][PF6], 
Fe(didpa)(CO)2, and [Fe(Hdidpa)(CO)2][PF6] were synthesized. The Fe(didpa)Cl2 was reduced under CO 
and protonated in the secondary coordination sphere, leading to the doubly reduced, protonated 
species, Fe(didpa)(CO)2. Electrochemistry was employed to measure the redox potential of the neutral 
iron PDI complex as well as the direduced species. The cyclic voltammograms showed a 105 mV shift 
upon protonation of the secondary coordination sphere.  
Fe(PDI) complexes with a 15-c-5 crown ether were capable of chelating alkali metal ions in the pocket of 
the crown. The encapsulation of Li+ and Na+ to the 15c5PDI complex were analyzed in the solid-state and 
in solution through X-ray crystallography and 1H NMR. The electrochemistry of these compounds was 
also examined in DCM, MeCN, and THF. There was only a small shift in the redox event of the compound 
upon addition of either Na+ or Li+ into the system. There is a shift of 50 mV observed in the Eox of the 
system upon encapsulation of Li+, only when the cyclic voltammetry is run in DCM.  On the other hand, 
encapsulation of Na+ causes a shift of 50 mV in the Eox when the CV is run in DCM, but there is also a 50 
mV in the Ered when the CV is run in THF. This provides us with highly reduced complexes with pendant 
redox-inactive Lewis acids in the secondary coordination sphere.   
The versatility of the didpa ligand allowed us to explore nitrite and nitrate reduction. Both of 
these chemical transformations require the use of both protons and electrons to achieve reduction to 
NO. Addition of sodium nitrite to [Fe(Hdidpa)(CO)2][PF6] resulted in the synthesis of a five-coordinate 
dinitrosyl iron complex (DNIC). Through IR spectroscopy, it was also determined that the DNIC complex 
can be synthesized by reaction of [Fe(Hdidpa)(CO)2][PF6] with TBANO3 in THF at 80 C.  A series of 
control experiments showed that the protonated state of the secondary coordination plays a vital role in 
the reduction of both NO3- and NO2-. 
In an effort to determine the products of these reactions, the headspace analysis via FTIR was taken 
after complete reaction of [Fe(Hdidpa)(CO)2][PF6] with TBANO3. The results showed that NO gas is not 
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one of the products produced in the reaction. Ion chromatography of the reaction solution was also 
analyzed. The results showed the presence of NO3- after complete reaction of [Fe(Hdidpa)(CO)2][PF6] 
with TBANO3.The ion chromatography results provide enough information to determine how much NO3- 
is not being used up in the reaction. However, these experiments are ongoing.  
The DNIC reaction will be further studied to determine the remaining products which will in turn 
allow us to determine the mechanism of the DNIC formation. Protonation of the secondary coordination 
sphere in the DNIC will also allow us to explore the effects that modulating the secondary coordination 









General Methods. All air sensitive experiments were performed using standard Schlenk procedures or in 
an MBraun glovebox under N2 atmosphere. Reagents were purchased from commercial sources and used 
as received with the exception of N,N-(diisopropyl)ethylenediamine, which was distilled immediately 
before use. The asymmetric PDI ligand [(ArN=C(CH3))C2H3N((CH3)C=O] (Ar =2,6-iPr-C6H3) was synthesized 
according to a literature procedures.39 All solvents used here were dried and deoxygenated with a 
PureSolv solvent purification system (CuO and alumina columns).  Infrared spectra were recorded on a 
Thermo Scientific Nicolet iS10 FT-IR spectrometer equipped with an ATR accessory. Gas infrared spectra 
were obtained on a Thermo Scientific Nicolet 6700 spectrometer equipped with a deuterated triglysine 
sulfate (DTGS) detector using 10 mm NaCl windows.  1H and 13C NMR spectra were recorded on a Unity 
Inova 500 MHz FT-NMR and Bruker 500 MHz FT-NMR spectrometer.  Unless otherwise noted, the data 
are reported in ppm, using the solvent resonance as the internal standard. The solution magnetic 
susceptibilities were calculated using Evan’s method NMR measurements.60 Solid-state magnetic 
susceptibilities were recorded on a Johnson Matthey MSB-1 magnetic susceptibility balance, calibrated 
with HgCo(SCN)4. Diamagnetic correction factors were calculated from Pascal’s constants.105 Elemental 
analyses were performed by ALS in Tucson, AZ. UV-Vis absorbance spectra were obtained using a Jasco 
UV-Vis/NIR spectrometer in 1 cm quartz cuvette. 
1H NMR Titrations. In a typical experiment, a sample of Fe(15c5PDI)(CO)2 (45 mmol) in CD3CN (600 μL) was 
added to a sealable NMR tube with an injectable screw cap. Either NaPF6 or LiPF6 in CD3CN were titrated 
in the sealed NMR tube in varying aliquots. The resulting mixture was vigorously shaken for 15 s and 
inserted into the NMR probe where it was allowed to equilibrate at 298 K for 10 min before a spectrum 
was obtained. The process was repeated until the titration was complete. 
1H NMR titrations.  In a typical experiment, a sample of either [Zn(Hdidpa)Cl2][PF6] or [Zn(Hdidpa)Br2][PF6] 
(14 mmol) in CD2Cl2 (600 L) was added to a sealable NMR tube with an injectable screw cap.  A hydrogen 
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bond acceptor such as DMF-d7 was titrated in the sealed NMR tube in varying aliquots.  The resulting 
mixture was vigorously shaken for 15 seconds and inserted into the NMR probe where it was allowed to 
equilibrate at 298 K for 10 minutes before a spectrum was obtained.  The process was repeated until the 
titration was complete. 
pKa Determination. pKa values in acetonitrile were determined by NMR spectroscopy and are the 
average of three self-consistent trials. In a typical experiment, 10.7 mg (0.0183 mmol) of 
[Zn(Hdidpa)Cl2][PF6] (6) was combined with 1.61 mg (0.0159 mmol) of triethylamine (pKa = 18.82) and 
dissolved with CD3CN. The solution was transferred to an NMR tube and allowed to equilibrate for 60 
min. before obtaining an NMR spectrum. The chemical shifts were measured using tetramethylsilane 
(TMS) as the internal standard. The equilibrium populations were determined by NMR, and the 
equilibrium concentration was determined from using the equation χA = (δeq – δB)/(δA – δB), where χA is 
the mole fraction of the conjugate acid, and δ refers to the measured chemical shift of a given peak at 
equilibrium (eq) and for pure samples of the conjugate acid (A) and base (B). Once the equilibrium 
concentrations were obtained, the pKa value was calculated utilizing Hess’s law. 
UV-Vis Titrations. In a glove box, Zn(didpa)Cl2 stock solutions were diluted to the desired concentration 
and the solution was transferred to a septum-sealed cuvette and removed from the glove box. NBu4OH 
stock solutions were prepared and were added to the septum-sealed cuvettes.  
Mössbauer Spectra. Mössbauer spectra were recorded at room temperature with a constant-acceleration 
spectrometer (Wissel GMBH, Germany) in a horizontal transmission mode using a 50 mCi 57Co source.  
Approximately 0.080 g of sample was crushed in a Mössbauer sample holder and a drop of Paratone-N 
was used to cover the sample to prevent oxidation. Data acquisition varied from 2 days to 7 days to get a 
statistically reasonable spectrum for each sample to analyze. The velocity scale was normalized with 
respect to metallic iron at room temperature; hence all isomer shifts were recorded relative to metallic 
iron. The Mössbauer spectra were fitted by assuming Lorentzian line shapes using the NORMOS (Wissel 
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GMBH) least-square fitting program. The isomer shifts and quadrupole splitting parameters were 
determined from the fitted spectra. 
Electrochemistry. Cyclic voltammetry was carried out using a Pine Wavenow potentiostat with a 
standard three-electrode electrochemical cell consisting of a glassy carbon working electrode, a 
platinum auxiliary electrode, and a freshly prepared Ag/Ag+ reference electrode with a vycor tip filled 
with acetonitrile. All potentials were internally referenced to the ferrocene redox couple. Unless 
otherwise noted, experiments were carried out under a dinitrogen atmosphere at room temperature 
using 0.001 M methylene chloride, THF, or acetonitrile solutions of the analyte and 0.100 M tetra(n-
butyl)ammonium hexafluorophosphate (TBAPF6) as the supporting electrolyte. All reversibility studies 
were carried out at 50, 100, 150, 200 and 250 mV/s. 
Computational Methods 
Molecular geometries were optimized and hydrogen bond strengths computed using density functional 
theory (DFT) within the Perdew–Burke–Ernzerhof (PBE) functional,106 using the VASP package107 and 
projector augmented wave (PAW) potentials.108 DFT-PBE has been shown to capture hydrogen bond 
strengths with an error of about 1 kcal/mol.109 A plane-wave cutoff of 400 eV was used throughout. In 
each of these calculations, an isolated molecule or ion was placed in a large cubic unit cell, surrounded 
by approximately 12 Å of vacuum space or more in all directions. Dipole corrections to the total energy 
were used to account for interactions introduced by periodic boundary conditions. 
Crystallographic Data Collection and Structure Determination 
Diffraction intensities for 3-10 were collected at 173(2) K, 200(2) K, and 223(2) K on a Bruker Apex CCD 
diffractometer using MoKα radiation λ = 0.71073 Å or CuKα radiation λ = 1.54178 Å. Space groups were 
determined based on systematic absences. Absorption corrections were applied by 
SADABS.110 Structures were solved by direct methods and Fourier techniques and refined on F2 using full 
matrix least-squares procedures. All non-H atoms were refined with anisotropic thermal parameters. All 
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H atoms in 7 and 9 and H atoms at the N atoms in 6 and 8 involved in N–H···Cl H-bonds were found in 
the residual density and refined with isotropic thermal parameters. All other H atoms in the investigated 
structures were refined in calculated positions in a rigid group model. Crystals of 3, 6, and 8 were very 
thin plates, and diffraction intensities at the high angles were very weak. Diffraction at high angles 
for 2 was weak as well. In all cases, diffraction data were collected up to 2θmax = 56°, but only reflections 
with 2θmax = 48° (6) and 50° (3, 5, and 8) were involved in the final refinements. Diffraction data 
for 5 were collected up to 2θmax = 133°, but only reflections with 2θmax = 120° were involved in the final 
refinements. Even with such restrictions, X-ray diffraction data provide an appropriate ratio of number 
of measured reflections per refined parameters. The refinement shows that a solvent pentane molecule 
in 8 and a solvent OEt2 molecule in 7 are disordered around inversion centers. The solvent pentane 
molecule in 8 is partially occupied in its position; there is 0.25(C5H12) per the main cation/anion pair. 
These disordered solvent molecules were treated by SQUEEZE.111 The corrections of the X-ray data by 
SQUEEZE are 51 electron/cell vs the required value of 42 electron/cell in 10 and 85 electron/cell vs the 
required value of 84 electron/cell in 8. The Flack parameter in 10 is 0.008(8). All calculations were 
performed by the Bruker SHELXTL (v. 6.10) package.2 
Crystallographic Data Collection for 15c5PDI complexes. Diffraction intensities for 12, 13 and 14 were 
collected at 173 K on a Bruker Apex2 CCD diffractometer using MoKα radiation λ = 0.71073 Å. Space 
groups were determined based on systematic absences (13 and 14) and intensity statistics (12). 
Absorption corrections were applied by SADABS. Structures were solved by direct methods and Fourier 
techniques and refined on F2 using full matrix least-squares procedures. All non-H atoms were refined 
with anisotropic thermal parameters. H atoms in all structures were refined in calculated positions in a 
rigid group model. Solvent Et2O molecule in 14 highly disordered over inversion centers was treated by 
SQUEEZE111; corrections of the X-ray data by SQUEEZE (88 electron/cell) is close to the S5 required value 
of 84 electron/cell for two Et2O solvent molecules in the full unit cell. Solvent CH2Cl2 molecule in 3 was 
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refined with restrictions; the value of 1.73 Å was used as a target in the refinement for corresponding C-
Cl bonds. For all crystals diffraction at high angles relatively weak due to flexibility of the O5-macrocycle 
in the crystal structures. All diffraction data were collected up to 2θmax = 56.0°, but only reflections 
with 2θmax = 50.0° have been used in the refinement. As it can be expected in all the structures there 
are significant elongations for atom thermal parameters in the O5-macro-cycle due to its flexibility. It 
was found that the compound FeCl2L(O5(C2H4)5) (1) has a structure similar that for 12, but O5-macrocycle 
in this structure is highly disordered and we could not find solution for this disorder. All calculations 
were performed by the Bruker SHELXL-2013 package.112 
Didpa (2). The ligand [(2,6-iPrC6H3)N=CMe)(N(iPr)2C2H4)N=CMe)C5H3N] (didpa) was synthesized with 
starting materials [(2,6-iPrC6H3)N=CMe)(O=CMe)C5H3N] (1.0 g, 3.10 mmol) and an excess of N,N-
diispropylethylenediamine (4.14 g,28.70 mmol)  in a 20-mL pressure vial. The vial was heated in silicon 
oil at 80  ˚C for 48 hours, yielding a dark yellow solution. The solution was transferred to a 50 mL round 
bottom flask where 10 mL of dry methanol was added and placed in the freezer for 6 hours. The 
resulting pale yellow solid was filtered in a Buchner funnel and washed with cold methanol.  FTIR: 1640 
cm-1 (C=N). 1H NMR, 500 MHz (CD2Cl2) 
 
Zn(didpa)Cl2 (3). The didpa ligand (0.50 g, 1.12mmol) was dissolved in approximately 10 mL of CH2Cl2. 
One equivalent of ZnCl2 (0.15 mg, 1.12 mmol) and stir bar were added to the pale yellow solution. The 
solution was allowed to stirred overnight, yielding a cloudy yellow-orange solution. The solvent was 
removed by in vacuo, redissolved in CH2Cl2, and layered with diethyl ether. Yellow-orange crystals 
resulted in 95% yield (2.48 g, 4.24 mmol). FTIR (ATR): 1639, 1585 cm-1 (C=N). 1H NMR (500 MHz, CD2Cl2) 
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 8.59 (t, 1H), 8.42 (d, 1H), 8.38 (d, 1H), 7.31 (m, 3H), 3.83 (t, 2H), 8.70 (m, 2H), 2.84 (m, 4H), 2.43 (s, 3H), 
2.25 (s, 3H), 1.15 (t, 12 H), 1.06 (d, 12 H). 13C NMR (500 MHz, CD2Cl2)  15.3, 18.7, 20.6, 22.5, 22.9, 24.1, 
24.6, 28.21, 44.9, 122.9, 123.8, 125.3, 125.6, 126.1, 138.9, 142.3, 143.4, 148.3, 149.7, 164.3 (C=N). Anal. 
Calc’d for C29H44Cl2ZnN4: C, 59.54; H, 7.58, N, 9.58. Found: C, 59.79; H, 7.08; N, 9.55 
Zn(didpa)Br2 (4). A 20 mL scintillation vial was charged with 2 (0.50 g, 1.12 mmol), approximately 10 mL 
of CH2Cl2, ZnBr2 (0.25 g, 1.12 mmol), and a stir bar.  The resulting yellow-orange solution stirred 
overnight forming a yellow solution with a yellow/orange precipitate. The solvent was removed in vacuo 
and redissolved in 5 mL of CH2Cl2. The solution was layered with diethyl ether for 1 day resulting in 
yellow/orange crystals identified as 4 (88% yield) (0.53 g, 0.98 mmol).  FTIR (ATR): 1636, 1584 cm-1 
(C=N).  1H NMR (500 MHz, CD2Cl2) δ 8.43 (t, 1H), 8.21 (d, 2H), 7.26 (s, 3H), 4.07 (t, 2H), 3.01 (m, 6H), 2.63 
(s, 3H), 2.37 (s, 3H), 1.30 (t, 6 H), 1.03 (d, 18 H). 13C NMR (500 MHz, CD2Cl2) δ 164.6 (C1=N1), 161.7 
(C2=N2), 149.3147.9, 143.7, 142.4, 138.9, 126.1, 125.9, 125.7, 123.8, 52.2, 49.1, 45.4, 28.4, 24.6, 24.5, 








Fe(didpa)Cl2 (5).  In a 20 mL scintillation vial, the didpa ligand (0.400 g, 0.892 mmol) was dissolved in 
approximately 9 mL CH2Cl2. A solution of FeCl2 (0.113 g, 0.892 mmol) in 1 mL THF and a stir bar were 
added to the vial. The resulting blue solution was stirred overnight. The solvents were removed in vacuo 
yielding a blue solid. The solid was redissolved with approximately 5 mL of CH2Cl2 and then filtered 
through a celite plug into a scintillation vial. The filtrate was carefully layered with pentane and set aside 
for one day, after which blue crystals of 5 were isolated in 78% yield (0.400 g, 0.696 mmol).  FTIR (ATR): 
1620, 1581 cm-1 (C=N). 1H NMR (500 MHz, CD2Cl2)  −23.51 (s, 2H), −15.35 (s, 2H), −3.70 (s, 9H), −2.49 (s, 
5H), −1.35 (s, 1H), 1.81 (s, 6H), 17.64 (s, 1H), 41.62 (s, 1H), 78.53 (s, 1H), 83.44 (s, 1H), 157.27 (s, 1H). μeff: 
5.8 μB (solid); 5.7 μB (solution). Anal. Calc’d for C29H44Cl2FeN4: C, 60.53; H, 7.71; N, 9.74. Found: C, 60.17; 
H, 7.77; N, 9.62eff: 5.75 B (solid); 5.68 B (solution).  Anal calcd for C29H44Cl2FeN4: C, 60.53; H, 7.71; N, 
9.74 Found: C, 60.17; H, 7.77; N, 9.62. 
[Zn(Hdidpa)Cl2][PF6] (6). In a scintillation vial equipped with a stir bar, complex 3 (0.100 g, 0.137 mmol), 
was dissolved in approximately 5 mL CH2Cl2.  In a separate 20 mL scintillation vial, NH4PF6 (56.8 mg, 
0.342 mmol) was dissolved in approximately 3 mL dry CH3OH and allowed to stir.  After stirring for 10 
min., the solution of NH4PF6 in CH3OH was added to the scintillation vial containing 3.  The resulting 
yellow-orange solution was stirred overnight.  The solvents were removed in vacuo, producing a 
yellowish orange solid.  The solid was redissolved with approximately 5 mL of CH2Cl2 and then filtered 
through a celite plug. The filtrate was layered with diethyl ether and the vial was placed in freezer for 48 
h to crystallize.  The resulting yellowish orange crystals were identified as [Zn(Hdidpa)Cl2][PF6] (6) (89% 
yield) (0.089 g, 0.122 mmol).   FTIR (ATR): 1642, 1586 cm−1 (C=N); 832 cm−1 (PF6−). 1H NMR (500 MHz, 
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CD2Cl2) δ 8.60 (t, 1H), 8.50 (s, 1H), 8.46 (d, 1H), 8.36 (d, 1H), 7.33 (m, 3H), 4.37 (t, 2H), 3.86 (sep, 2H), 
3.74 (t, 2H), 2.90 (sep, 2H), 2.75 (s, 3H), 2.45 (s, 3H), 1.46 (m, 12 H), 1.30 (d, 6 H), 1.06 (d, 6 H). 13C NMR 
(500 MHz, CD3CN) expected: 20; reported, 19; δ 15.3, 18.7, 23.7, 24.26, 28.1, 46.8, 47.0, 55.9, 97.3, 
124.1, 126.7, 127.4, 128.0, 139.5, 144.4, 147.8, 148.6, 167.7 (C1=N1), 167.9 (C2=N2). Anaytical. Calc’d for 
C29H45Cl2F6ZnN4P: C, 47.65; H, 6.21; N, 7.67. Found: C, 47.25; H, 6.02; N, 7.64. 
[Zn(Hdidpa)Br2][PF6] (7). A 20-mL scintillation vial was charged with 5 (0.100 g, 0.122 mmol), 
approximately 5 mL CH2Cl2, and stir bar. In a separate 20 mL scintillation vial, NH4PF6 (40.0 mg, 0.245 
mmol) was dissolved in approximately 3 mL dry CH3OH and stirred.  After stirring for 10 min., the 
solution of NH4PF6 in CH3OH was added to the vial of 4.  The resulting yellowish orange solution was 
stirred overnight.  The solvents were removed in vacuo, producing a yellowish orange solid.  The solid 
was redissolved with approximately 5 mL of CH2Cl2 and filtered through a celite plug. The filtrate was 
layered with diethyl ether and the vial was placed in freezer for 48 h to allow for crystallization.  The 
yellow/orange crystals formed were identified as 7 (95% yield) (0.0950 g, 0.116 mmol).     FTIR (ATR): 
1644, 1591 cm-1 (C=N); 835 cm-1 (PF6-). 1H NMR (500 MHz, CD2Cl2)  8.55 (t, 1H), 8.41 (d, 1H), 8.32 (d, 
1H), 7.78 (s, 1H) 7.28 (m, 3H), 4.37 (t, 2H), 3.83 (t, 2H), 3.71 (m, 2H), 2.90 (sep, 2H), 2.72 (s, 3 H), 2.42 (s, 
3H), 1.40 (d, 12H), 1.28(d, 6H), 1.03 (d, 6H). 13C NMR (500 MHz, CD2Cl2) expected: 20; reported, 19; δ 
167.3 (C1=N1), 166.6 (C2=N2), 148.8, 147.7, 144.6, 141.1, 139.3, 127.3, 127.1, 126.9, 124.2, 56.3, 47.4, 
46.8, 28.5, 24.6, 19.3, 18.5, 17.2, 16.3.  Anal. calcd for C29H45Br2F6ZnN4P: C, 42.49; H, 5.53; N, 6.83. 








[Fe(Hdidpa)Cl2][PF6] (8). In a 20 mL scintillation vial, 5 (0.100 g, 0.174 mmol) was dissolved in 
approximately 5 mL CH2Cl2. With stirring, a solution of NH4PF6 (56.7 mg, 0.348 mmol) dissolved in 3 mL of 
CH3OH was added to the solution of 5. The solution was stirred overnight. The solvents were removed in 
vacuo and redissoved in approximately 5 mL of CH2Cl2. After being filtered through a celite plug into a 
clean 20 mL scintillation vial, the filtrate was layered with pentane and stored in the freezer for 24 h to 
crystallize 8 in 92% yield (0.115 g, 0.160 mmol). FTIR (ATR): 1623, 1582 cm-1 (C=N); 833 cm-1 (PF6-). 1H NMR 
(500 MHz, CD2Cl2)  -23.51 (s, 2 H), -15.35 (s, 2H), -3.70 (s, 9H), -2.49 (s, 5H), -1.35 (s, 1H), 1.81 (s, 6H), 
17.64 (s, 1H), 41.62 (s, 1H), 78.53 (s, 1H), 83.44 (s, 1H), 157.27 (s, 1H). eff: 4.77 B (solid); 4.70 B (solution).  
Anal calcd for C29H45Cl2F6FeN4P: C, 48.28; H, 6.29; N, 7.77. Found: C, 47.03; H, 6.56; N, 7.47.   
Fe(didpa)(CO)2 (9).  In a nitrogen filled MBraun glovebox, a Fisher Porter tube was charged with complex 
5 (0.150 g, 0.261 mmol), sodium mercury amalgam (400 mg, 5%Na), a stir bar, and approximately 5 mL 
of CH2Cl2 to produce a blue color solution. The tube was closed with a pressure valve and charged with 
20 psi of CO and left to stir vigorously overnight. The solvent was then removed in vacuo, redissolved 
with approximately 10 mL of Et2O, and filtered through a glass wool, celite plug. Slow evaporation of 
Et2O resulted in dark green crystals of 9 (65% yield) (0.0950 g, 0.170 mmol). FTIR (ATR): 1940, 1872 cm-1 
(C=O).  1H NMR (500 MHz, CD2Cl2)  8.07 (q, 3H), 7.51 (t, 1H), 7.25 (m, 2H), 4.25 (t, 2H), 3.10 (sep, 2H), 
2.88 (t, 2H), 2.73 (s, 3H), 2.51 (sep, 2H), 2.36 (s, 3 H), 1.26 (d, 6 H), 1.05 (d, 18 H). 13C NMR (500 MHz, 
CD2Cl2) δ 214.9 (C=O), 155.8 (C1−N1), 155.166 (C2−N2), 149.8, 145.8, 140.3, 126.0, 123.2, 120.8, 119.9, 
117.2, 62.7, 48.9, 47.8, 27.2, 24.4, 20.0, 20.7, 16.3, 14.3. Anal. calcd for C31H44O2FeN4: C, 66.42; H, 7.91; 
N, 9.99. Found: C, 66.32; H, 8.01; N, 9.72. 
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[FeH(didpa)(CO)2][PF6] (10). A 20 mL scintillation vial was charged with 9 (0.150 g, 0.231 mmol) and 
dissolved in approximately 5 mL of CH2Cl2. In a separate 20 mL scintillation vial, NH4PF6 (75.2 mg, 0.461 
mmol) dissolved in 3 mL of dry CH3OH was stirred for 10 min. Both solutions were then mixed together 
and stirred overnight. The solvents were removed in vacuo and the resulting solid was redissolved in 
CH2Cl2. The solution was filtered through celite into a clean scintillation vial, and then carefully layered 
with ether to allow for crystallization. The resulting dark green crystals were washed with ether and 
dried under vacuum. (80% yield) (0.130 g, 0.184 mmol).  FTIR (ATR): 1946, 1879 cm-1 (C=O), 831 cm-1 
(PF6-).  1H NMR (500 MHz, CD2Cl2)  8.18 (m, 2H), 7.60 (m, 1H), 7.35 (t, 1H), 7.28 (d, 2H), 4.65 (m, 2H), 
3.82 (m, 2H), 3.48 (m, 2H), 2.75 (s, 3H), 2.51 (m, 5H), 1.51 (d, 12H), 1.27 (m, 6 H), 1.06 (d, 6 H). 13C NMR 
(500 MHz, CD2Cl2) δ 214.9 (C=O), 158.1 (C1−N1), 156.3 (C2−N2), 149.2, 145.5, 145.1, 140.1, 126.5, 123.6, 
122.1, 121.5, 118.5, 48.4, 27.3, 24.4, 23.9, 16.6, 14.5. Anal. calcd for C31H45F6O2FeN4P: C, 52.70; H, 6.42; 
N, 7.93. Found C, 52.01; H, 6.70; N, 7.53. 
 
 
Fe(15c5PDI)Cl2 (11).  In an N2 filled MBraun glovebox, a 100  mL Schelnk flask equipped with a stir bar was 
charged with the asymmetric PDI ligand [(ArN=C(CH3))C2H3N((CH3)C=O] (0.250 g, 0.775 mmol) and FeCl2 
(98.3 mg, 0.775 mmol). Approximately 20 mL of ethanol was added to the round bottom Schlenk flask. 
The solution was heated to 80 ˚C for 30 min under N2 gas while stirring.  A solution of 2-Aminomethyl-15-
crown-5 (193 mg, 0.775 mmol) dissolved in approximately 10 mL of ethanol was slowly syringed into the 
flask and the solution was left to heat at 80 ˚C for 12 h under N2 gas. The solvent was removed in vacuo, 
yielding a dark blue solid. Back in the glovebox, the resulting solid was redissolved in 5 mL of CH2Cl2 and 
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filtered through a celite plug. The filtrate was carefully layered with pentane in order to obtain the dark 
blue crystals identified as Fe(15c5PDI)Cl2 (11) (90% yield). Anal Calc’d for C32H47Cl2FeN3O5: C, 56.48; H; 6.96; 
N, 6.18. Found: C, 56.67; H; 7.13; N, 6.48.  
 
 Fe(15c5PDI)(CO)2 (12). In a nitrogen filled MBraun glovebox, a Fisher Porter tube was charged with complex 
complex 11 (0.150 g, 0.225 mmol), sodium mercury amalgam (400 mg, 5%Na), a stir bar, and 
approximately 5 mL of CH2Cl2 to produce a blue color solution. The tube was closed with a pressure valve 
and charged with 20 psi of CO and left to stir vigorously overnight. The solvent was removed in vacuo and 
brought back into the glovebox. The resulting green solid was redissolved in 5 mL of diethyl ether and 
filtered through a celite plug. Slow evaporation of the diethyl ether solution resulted in dark green crystals 
identified as (12) in 90% yield (0.135 g, 0.203 mmol). FTIR (ATR): 1946, 1882 cm−1 (C=O). 1H NMR (500 
MHz, CD3CN) δ 8.11 (q, 2H), 7.52 (t, 1H), 7.24 (m, 3H), 4.45(q, 2H), 4.15 (q, 2H), 4.05 (m, 1H),3.56 (m, 17H), 
2.72 (s, 3H), 2.52 (sep, 1H), 2.28 (s, 3H), 1.20 (m, 6H), 1.0 (m, 6H). 13C NMR (500 MHz, CD3CN) δ 14.57, 
15.79, 23.54, 23.62, 23.91, 27.24, 62.36, 71.40, 82.54, 118.02, 121.03, 121.87, 123.43, 126.21, 139.92, 
140.39, 144.39, 145.97, 149.73, 155.51, 158.85, 212.99, 216.99. Anal Calc’d for C34H47FeN3O7: C, 61.35; H, 
7.12; ; N, 6.31. Found: C, 61.05; H; 7.28; N, 6.57.  
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[Fe(15c5PDI)(CO)2 Li][PF6] (13). A 20 mL scintillation vial was charged with compound (12) (0.100 g, 0.150 
mmol), LiPF6 (0.023 g, 0.150 mmol), a stir bar, and approximately 2 mL of CH3CN were added to a 20 mL 
scintillation vial. The dark green solution was stirred overnight. The solvent was removed in vacuo and 
then redissolved in 5 mL of CH2Cl2 before being filtered through Celite. The solution was carefully layered 
with pentane and set aside for crystallization, yielding dark green crystals identified as [Fe(15c5PDI)(CO)2 
Li][PF6] (14) in 70% yield (0.070 g, 0.086 mmol). FTIR (ATR): 1931, 1866 cm−1 (C=O), 824 cm−1 (PF6−). 1H 
NMR (500 MHz, CD3CN) δ 8.17 (d, 2H), 7.58 (t, 1H), 7.27 (m, 3H), 4.50 (q, 2H), 4.29 (q, 2H), 4.25 (m, 1H), 
3.61 (m, 17H), 2.72 (s, 3H), 2.54 (sep, 1H), 2.30 (s, 3H), 1.21 (d, 6H), 1.00 (d, 6H). 13C NMR (500 MHz, 
CD3CN) δ 14.33, 14.39, 23.39, 23.32, 23.53, 23.60, 23.69, 23.76, 24.07, 24.00, 27.18, 27.23, 27.29, 60.28, 
68.02, 68.65, 68.79, 79.86, 122.12, 123.49, 126.39, 139.75, 139.82, 140.31, 140.37, 144.48, 149.53, 
156.66, 158.19, 212.66, 217.16. Anal. Calcd for C34H47F6FeN3LiO7P: C, 49.95; H, 5.80; N, 5.14. Found: C, 
50.22; H, 5.97; N, 5.47. 
 
[Fe(15c5PDI)(CO)2 Na][PF6] (14). Compound (12) (0.100 g, 0.150 mmol), NaPF6 (0.025 g, 0.150 mmol), a stir 
bar, and approximately 2 mL of CH3CN were added to a 20 mL scintillation vial. The dark green solution 
was stirred overnight. The solvent was removed in vacuo and then redissolved in 5 mL of CH2Cl2 before 
being filtered through a celite plug. The solution was carefully layered with pentane and set aside for 
crystallization, yielding dark green crystals identified as (13) 70% (0.070 g, 0.084 mmol) yield. FTIR (ATR): 
1936, 1868 cm−1 (C=O), 835 cm−1 (PF6−). 1H NMR (500 MHz, CD3CN) δ 8.20 (d, 2H), 7.61 (t, 1H), 7.29 (m, 
3H), 4.53 (q, 2H), 4.32 (q, 2H), 4.20 (m, 1H), 3.61(m, 17H), 2.75 (s, 3H), 2.54 (sep, 1H), 2.33 (s, 3H), 1.23 
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(m, 6H), 1.02 (m, 6H). 13C NMR (500 MHz, CD2Cl2) δ 14.66, 16.18, 23.74, 24.35, 24.47, 27.29, 27.24, 59.96, 
81.03, 117.97, 121.30, 121.37, 123.40, 123.45, 126.17, 139.81, 140.41, 144.89, 156.06, 158.01, 212.46, 
217.28. Anal. Calcd for C34H47F6FeN3NaO7P: C, 48.99; H, 5.68; N, 5.04. Found: C, 49.21; H, 5.46; N, 5.34. 
Synthesis of [Fe(Didpa)(NO)2][PF6] (15). Compound 10 (0.050 g, 0.071 mmol)) was dissolved in 8 mL THF 
and stirred for 30 min. A solution of NaNO2 (0.005 g, 0.072 mmol) dissolved in 2 mL of CH3OH was added 
dropwise to the green solution of 10. The solution left to stir overnight. A color change from green to red 
brown is observed after stirring overnight. The solvent was removed in vacuo, yielding a red-brown solid. 
The red-brown solid was redissolved with approximately 5 mL of THF before being filtered through a 
pipette packed with glass wool and celite into a clean 20 mL scintillation vial. The filtrate was carefully 
layered with pentane placed in the glovebox freezer for 48 h resulting in dark brown crystal identified as 
15 through X-ray crystallography. FTIR (ATR): 1789, 1716 cm-1 (NO); 837 cm-1 (PF6-). 57Fe Mossbauer: δ = 




Reactivity of 10 with Na15NO2 to form [Fe(didpa)(15NO)2][PF6] (15). Compound 10 (0.050 g, 0.071 mmol) 
was dissolved in 8 mL THF and stirred for 30 min. A solution of Na15NO2 (0.005 g, 0.072 mmol) dissolved 
in 2 mL of CH3OH was added to the green solution of 10. The solution was allowed to stir overnight. The 
solvents of the resulting red-brown solution was removed in vacuo, yielding a brown solid. The solid was 
redissolved with approximately 3 mL of THF and then filtered through a pipette packed with glass wool 
and celite. The filtrate was carefully layered with pentane for crystallization. FTIR (solid): 1755, 1684 cm-1 
(NO); 831 cm-1 (PF6-). 
Reactivity of 10 with TBANO3 to form [Fe(didpa)(NO)2][PF6]. In an N2 filled glovebox, a 20 mL pressure 
vial was charged with compound 10 (0.050 g, 0.071 mmol), TBANO3 (0.022 g, 0.071 mmol), and 5 mL of 
THF. The vial was tightly closed, taken out of the glovebox, and placed in an 80 ˚C silicone-based oil bath. 
The solution was left for 12 hours before being brought back into the glovebox. A color change from dark 
green to dark brown was observed and a liquid IR of the solution was obtained. The remaining solution 
was transferred to a 20 mL scintillation vial and the solvents were removed in vacuo. The brown solids 
were redissolved in THF and filtered through Celite. The filtrate was layered with THF and placed in the 
glovebox freezer to allow for crystallization.  
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Reactivity of 10 with TBA15NO3 to form [Fe(didpa)(15NO)2][PF6]. A 20 mL pressure vial was charged with 
compound 10 (0.050 g, 0.071 mmol), TBANO3 (0.022 g, 0.071 mmol), and 5 mL of THF. The vial was placed 
in an 80 ˚C silicone-based oil bath overnight. A color change from dark green to dark brown was observed 
and a liquid IR of the solution was obtained. The remaining solution was transferred to a 20 mL scintillation 
vial and the solvents were removed in vacuo. The brown solids were redissolved in THF and filtered 
through Celite. The filtrate was layered with THF and placed in the glovebox freezer to allow for 
crystallization. 
Reactivity of 10 with TBANO3 for analysis of NO gas in the headspace. In an N2 filled glovebox, compound 
10 (0.050 g, 0.071 mmol) dissolved in approximately 5 mL of THF were added to a Fisher Porter tube. The 
tube was closed with a pressure valve, taken out of the box, and placed in an 80 ˚C silicone-based oil bath 
for 12 hours. The Fisher Porter tube and a gas IR cell (NaBr plates) were attached to a t-valve and hooked 
to a Schlenk line. Once the lines were evacuated and air-free, the headspace from the Fisher Porter tube 
was allowed to freely flow into the gas cell IR. The valve of the IR cell was closed off and a spectrum was 
obtained, inspecting for NO gas.  
Reactivity of Fe(MeoPDI)(CO)2 with TBANO3. The Fe(MeoPDI)(CO)2  complex was synthesized according to 
literature procedures.12 A 20-mL pressure vial was charged with compound Fe(MeoPDI)(CO)2  (0.0500 g, 
0.0900 mmol), TBANO3 (0.0274 g, 0.0900 mmol), and 5 mL of THF. The vial was placed in an 80 ˚C silicone-
based oil bath overnight. A color change from dark green to dark brown was observed and a liquid IR of 
the solution was obtained. The remaining solution was transferred to a 20-mL scintillation vial and the 
solvents were removed in vacuo. The brown solids were redissolved in THF and filtered through Celite.  
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Crystallographic Data for 12: C34H47FeN3O7, M = 665.59, 0.45 x 0.09 x 0.07 mm, T = 193(2) K, Triclinic, space 
group  P-1, a = 8.6642(17) Å, b = 13.636(3) Å, c = 16.314(3) Å, α = 114.394(3),  = 103.191(4), γ = 
90.234(4), V = 1698.6(6) Å3, Z = 2, Dc = 1.301 Mg/m3, μ(Mo)  = 0.494 mm-1, F(000) = 708, 2θmax = 50.0°, 
33984 reflections, 5980 independent reflections [Rint = 0.0744],  R1 = 0.0575, wR2 = 0.1331 and GOF = 
1.006 for 5980 reflections (406 parameters) with I>2(I), R1 = 0.0962, wR2 = 0.1565 and GOF = 1.006 for 
all reflections, max/min residual electron density +1.147/-0.492  eÅ3. 
Crystallographic Data for 13: C36H52F6FeLiN3O7.5P, C34H47F6FeLiN3O7P 0.5(C4H10O), M = 854.56, 0.29 x 0.17 
x 0.13 mm, T = 173 K, Monoclinic, space group  P21/c, a = 16.879(5) Å, b = 15.800(5) Å, c = 16.933(6) Å,  
= 115.586(8), V = 4073(2) Å3, Z = 4, Dc = 1.394 Mg/m3, μ(Mo) = 0.487 mm-1, F(000) = 1788, 2θmax = 50.0°, 
29010 reflections, 7177 independent reflections [Rint = 0.0467],  R1 = 0.0848, wR2 = 0.2366 and GOF = 
1.023 for 7177 reflections (478 parameters) with I>2(I), R1 = 0.1111, wR2 = 0.2583 and GOF = 1.023 for 
all reflections, max/min residual electron density +1.347/-1.325  eÅ3. 
Crystallographic Data for 14: C35H48Cl2F6FeN3NaO7P, M = 917.47, 0.26 x 0.23 x 0.21 mm, T = 173 K, 
Monoclinic, space group  P21/c, a = 18.4136(13) Å, b = 13.6524(9) Å, c = 16.8854(12) Å,  = 91.165(2), V 
= 4243.9(5) Å3, Z = 4, Dc = 1.436 Mg/m3, μ(Mo) = 0.603 mm-1, F(000) = 1900, 2θmax = 50.0°, 45328 
reflections, 7473 independent reflections [Rint = 0.0484],  R1 = 0.0653, wR2 = 0.1670 and GOF = 1.043 for 
7473 reflections (505 parameters) with I>2(I), R1 = 0.1045, wR2 = 0.2048 and GOF = 1.043 for all 




Figure S1. 13C NMR of 3, 500 MHz, CD2Cl2. 
 
Figure S2. 13C NMR of 4, 500 MHz, CD2Cl2. 
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Figure S3. 1H NMR of 5, 500 MHz, CD2Cl2. 
 









Figure S5. 13C NMR of 7, 500 MHz, CD2Cl2. 
 




Figure S7. 13C NMR of 9, 500 MHz, CD2Cl2. 
 












Figure S9. UV-visible spectra in CH2Cl2 of Fe(didpa)Cl2 (5) (blue line, 7.125×10-5 M), and   
[Fe(Hdidpa)Cl2][PF6] (8) (red line, 1.05×10-4 M).  
 
Figure S10. UV-visible spectra in CH2Cl2 of didpa (black line, 1.38×10-04 M), Zn(didpa)Cl2 (3) (red line, 




Figure S11. UV-visible spectra in CH2Cl2 of Zn(didpa)Br2 (4) (red line, 1.28×10-04 M), and 
[Zn(Hdidpa)Br2][PF6] (7) (blue line, 8.54 ×10-05 M).  
Figure S12. UV-visible spectra in CH2Cl2 of Fe(didpa)(CO)2 (9) (blue line, 3.835×10-5 M), and 







Figure S13. 1H NMR of Fe(15c5PDI)Cl2 (11), 300 MHz, CD2Cl2. 
 




Figure S16. 13C NMR of [Fe(15c5PDI)(CO)2 Li][PF6] (13), 500 MHz, CD3CN. 
 
 




Figure S17. 1H NMR spectrum of Fe(15c5PDI)(CO)2 [10 mM] +TBAP [1 M] (Top); Fe(15c5PDI)(CO)2 [40 
mM](Bottom), CD3CN. 
 
Figure S18. 1H NMR of [Fe(15c5PDI)(CO)2 Na][PF6] [10 mM] + TBAP [1 M] (Top); [Fe(15c5PDI)(CO)2 




Figure S19. 1H NMR of [Fe(15c5PDI)(CO)2 Na][PF6] [10 mM]+ TBAP [1 M] (Top); Fe(15c5PDI)(CO)2 [10mM]+ 




Figure S20. 1H NMR of [Fe(15c5PDI)(CO)2 Li][PF6] [10 mM]+ TBAP [1 M] (Top), [Fe(15c5PDI)(CO)2 Li][PF6] [32 
















Figure S21. 1H NMR of [Fe(15c5PDI)(CO)2 Li][PF6] [10 mM]+ TBAP [1 M] (Top), Fe(15c5PDI)(CO)2 [10 mM]+ 
TBAP [1 M] (Bottom), CD3CN. 
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Figure S22. Cyclic Voltammograms of Fe(15c5PDI)(CO)2 (black), [Fe(15c5PDI)(CO)2 Li][PF6] (red), 

































































Figure S23. Plot of reductive event, Ecathodic peak current versus square root of the scan rate for of 
Fe(15c5PDI)(CO)2 (12) (red), [Fe(15c5PDI)(CO)2 Li][PF6] (13) (blue), [Fe(15c5PDI)(CO)2 Na][PF6] (14) (green) in 
THF.    










Figure S25. 1H NMR spectra of 11.4 mM 3, and 1.5 equiv. NBu4SH in CD3CN with varying 
temperatures. 
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